Heilen Mit Vitalstoffen Pdf File

  1. Heilen Mit Vitalstoffen Pdf File Free
  1. Heilen mit Vitalstoffen. Spenden Sie jetzt mit Paypal. An2 triebschwierigkeiten,! Von allen Zell-Vitalstoffen ist Vitamin C mit Abstand der wichtigste. Idealgewicht, wenn wir ihn nicht. Mit einem effektiven Mittel den Alterungsprozess zu stoppen und hinter das Geheimnis der ewigen.
  2. Kreativkurs mit Thea Zedelmeier. Heilen mit Vitalstoffen Vitaminmangel und Testverfahren Ern Heilen mit Vitalstoffen: Wie Sie Krankheiten f. Heilen Mit Symbolen PDF - Free Ebook Download - ebookdig.biz is the right place for every Ebook Files. Medikamente sind wie Weltraumraketen, eine Zaubervorstellung, ein heftiger Schlag.
Ab Seite anzeigen:
Download 'Curriculum vitae. Dr. Joerg Gruenwald'

Kreativkurs mit Thea Zedelmeier. Heilen mit Vitalstoffen Vitaminmangel und Testverfahren Ern Heilen mit Vitalstoffen: Wie Sie Krankheiten f. Heilen Mit Symbolen PDF - Free Ebook Download - ebookdig.biz is the right place for every Ebook Files. Medikamente sind wie Weltraumraketen, eine Zaubervorstellung, ein heftiger Schlag.

  • Maja Weiner
  • vor 3 Jahren
  • Abrufe

Transkript

1 Personal Data Date of Birth: November 19, 1950 Place of Birth: Giessen, Germany Marital status: married, 3 children Address: Private Address: analyze & realize GmbH Waldseeweg 6, Berlin, Germany Tel.: +49 (30) Fax: +49 (30) Stolzingstr. 24, Berlin, Germany Tel.: +49 (30) Mobil: Current Functions Founder and Chief Scientific Advisor of analyze & realize ag, since 5/2013 President Herbalist & Doc Gesundheitsgesellschaft mbh, since1997 Professional Appointments President and Founder of analyze & realize ag, founded 2001 as successor of PhytoPharm Consulting founded in 1996 and Background Consulting founded in 1992 until 5/2013 Co-Founder and Board Member InQpharm since Chief Scientific Officer, Biotropics Malaysia Berhad, Malaysia, Managing Director Snowberry Beauty Assistant Professor University of Applied Sciences Berlin, since 2006 Chief Scientific Officer Nutri Pharma ASA, Denmark, Board Member Gruenwalder Gesundheitsprodukte GmbH, Associate Partner of Background Consultancy, President PhytoPharm Consulting Medical Director, Lichtwer Pharma GmbH, Berlin, FRG, Director of Clinical Research, Lichtwer Pharma GmbH, Berlin, FRG Head Lab. for Cytopathology, Institute for Arterosclerosis Research at the University of Muenster, Germany, Research Associate, Mallory Institute of Pathology, Boston University, School of Medicine, USA, Research Associate, Institute for Arteriosclerosis Research at the University of Muenster, Germany, Research Associate, Biologische Bundesanstalt Dossenheim, Germany, Postgraduate Training 2 nd Pathological Institute, Semmelweis Medical University, Budapest, Hungary, 1980 Pathological Institute, University of Groningen Netherlands, 1981 Education Goethe Gymnasium, Neu Isenburg University Heidelberg, BS 1972 University Heidelberg, MS Biology, 1975 University Heidelberg Ph.D. Botany, / 17

2 Languages German: mother tongue English: fluent French: fluent Honors Chairman: Health Ingredients official Conference, Industry Leaders Debate, Netherlands, Amsterdam December 2014 Committee Member Nutrition Capital Network (NCN) at Vitafoods, 2014, Geneva, Switzerland Chairman: Vitafoods International Conference 2014, Geneva, Switzerland Chairman: Health Claims Europe, 2 nd International Workshop, Anaheim CA, USA, March 2014 Chairman: Vitafoods International Conference 2013, Geneva, Switzerland Chairman: Health Ingredients Europe 2012, Frankfurt, Germany Chairman: Vitafoods International Conference 2012, Geneva, Switzerland Chairman: 5th International Workshop Nutrition & Health Claims Designing clinical studies for success, Brussels, Belgium, April 2010 Committee Member of the Committee of the Task Force on Natural Products & Herbal Industry, Malaysia, Keynote Speaker NATPRO Kuala Lumpur, Malaysia, March 2008 Chair: Phytotherapie-Kongress Berlin, Germany. Feb Chairman: Annual Meeting American Society of Pharmacognosy, Portland, USA, July 2007 Chairman: Vitafoods International Conference, Geneva, Switzerland, May 2007 Chairman: The Future of Nutraceuticals, Istanbul, Turkey; April 2007 Chairman: Regulations on Nutraceuticals, Brussels, Dec Chairman: Vitafoods International Conference, Geneva, Switzerland, May 2006 Chairman 2nd Annual World Obesity & Weight Loss Congress, Nutraceutical Track, Sep Chairman Garlic Symposium Washington, May 2005 Senior Advisor for Herbal Medicines of the Industrial Investment Council (ICC) of the German Federal Government (2004) Chairman: International Kava Conference (IKC 2004), Suva, Fiji, 2004 Keynote Speaker at Cadbury Symposium Green Day (2004) International Advisory Board: Globalization of Chinese Herbal Medicine, Shanghai, China 2004 Chairman: Vitafoods International Conference, Geneva, Switzerland 2004 Executive Director: International Kava Executive Council IKEC, 2003 to date Chairman: Vitafoods International Conference, Geneva, Switzerland 2003 Co-Chair: 3 rd International Workshop on Integrative Medicine, JAFRA (Japan Functional Food Research Association), Berlin 2002 Chairman: Herbals and Botanicals, Leatherhead Functional Food Conference London 2002 Chairman: Caribbean Herb Business Forum, Montego Bay, Jamaica 2002 Chairman: Namibian National Devils Claw Situation Analysis, Windhoek, Namibia 2002 Chairman: Worldnutra, San Diego, California 2002 Chairman: Nutraceuticals Functional Food Herbal Medicines: Successes and Opportunities in Consolidated Markets, Natural Products 2001 & Cosmeceuticals, London 2001 Chairman Back to the Roots: Herbals and Botanicals as 21 st Century Ingredients, Leatherhead Conference, 2000 Chairman: The International Nutraceutical Market, NutraPhex 2000 Conference, Amsterdam Chairman: Business Opportunities for Botanicals + Dietary Supplements in Europe, Global Business Research, Nutracon 99, Las Vegas, 1999 and Chairperson International Track, Nutracon 2000, Las Vegas Chairman: Utilizing and Capitalizing on the Benefits of Herbal Extracts, Frankfurt 1999 Chairman: Herbal Extracts As Food Ingredients, Medicines & Supplements, London, 1999, Herbal Extracts 2000 Session Chairman: Green Pharmaceuticals 98 Conference, Vancouver, Canada, 1998 Session Chairman: Hypericum as Anti-Depressant, Drug Information Association, 34 th Annual Meeting, Boston 1998 CV Dez2014.docx 2 / 17

3 Session Chairman: The Regulation and Classification of Hypericum in Europe, First International Symposium of St. John s Wort, Anaheim, California 1998 Workshop Chairperson: 'The Role of Botanical Supplements in Health: Research Advances and Directions' 16 th International congress of Nutrition, Montreal, Canada 1997 Session Chairman: 'Advantages/Disadvantages of Heterogeneous Botanicals vs Single Compounds. Drug Information Association, 33 rd Annual Meeting, Montréal, Canada 1997 Session Chairman: 'Opportunities and Challenges for Heterogeneous Botanical Products', 3 rd Drug Information Association Workshop on Botanicals: 'Botanical Testing: Developing the Scientific Evidence to Support the Medical Use of Heterogeneous Botanical Products ' in Cooperation with NIH and FDA, Washington DC, 1997 Chairman: 'International Garlic Research' Symposium at the Congress of the German Society for Phytomedicines in cooperation with ESCOP, Berlin 1996 Chairman: Seventh Muenster International Arteriosclerosis Symposium, 1993 Member of Publications committee: European Scientific Cooperative for Phytotherapy (ESCOP), since Member of the Drug Research and Drug Development Committee BPI (German Federation of Pharmaceutical Industries), since 1993 Member of the 'Grenzgebiet Arzneimittel' (Dietary Supplements) Committee BAH (German Federation of Proprietary Medicine Manufacturers), since 1995 Member of the International Committee BAH (German Federation of Proprietary Medicine Manufacturers), since Secretary: Second International Garlic Symposium, 1991 Member of the Board: German Society for Arteriosclerosis Research, Organizing Committee: 9 th European Atherosclerosis Society, 15 th Anniversary Meeting, 1989 Co-Chairman: Poster session of the Conference of the German Society for arteriosclerosis Research, 1988 Secretary: German Society for Arterosclerosis Research, Organizing Committee: 8 th European Conference on Vascular Biology, 1987 Co-Chairman: 7 th European Conference on Vascular Biology, 1986 Organizing Committee: 7 th European Conference on Vascular Biology, 1986 Co-Chairman: Poster session of the 7 th International Symposium on Atherosclerosis, 1985 Secretary: 4th Muenster International Arteriosclerosis Symposium, 1985 Organizing Committee: European Artery Club Secretary: German study group on arteriosclerosis research, Organizing Committee: Second Muenster International Arteriosclerosis Symposium, 1981 Professional Societies and Functions Member of the Vitafoods Europe Conference Executive Advisory Board 2014 Expert on Natural Ingredients for Pharmaceuticals, CBI, Mininstry of Foreign Affairs of the Netherlands, Peer Group Sessions of 2012, 2013 Member of the Vitafoods Europe Conference Executive Advisory Board 2013 Official EFSA partner for systematic review writing Member of the Vitafoods Europe Conference Executive Advisory Board 2012 Executive Director International Kava Executive Council (IKEC) since 2003 Scientific Advisory Board Sherbrooke Capital (150 Mio$ Venture Capital Fund) (since 1998) International Advisory Board of the Research Council of Complementary Medicine since 2006 Chairman International Committee AHPA American Herbal Products Association ( ) Advisor, FDA Office of Dietary Supplements ( ) Council for Responsible Nutrition Botanical/Quality Standards Committee ( ) Advisory Board Member of the Centrum Center for Nutrition Science (CCNS) ( ) United States Pharmacopoeia (USP) Member of the Ad Hoc Group on Botanicals ( ) German Society for Phytotherapy (since 1989) European Scientific Cooperative on Phytotherapy (ESCOP) ( ) International Atherosclerosis Society (since 1979) European Atherosclerosis Society (since 1980) American Heart Association, Fellow of the Council of Arteriosclerosis ( ) German Society for Atherosclerosis Research (since 1980) CV Dez2014.docx 3 / 17

4 Editor of international publications Editorial Board Member: Internationaljournal of Advanced Biological and Biomedical Research (IJABBR), since 2014 Editorial Board Member: International Journal of Clinical Medicine, since 2014 Editorial Board Member: Plant Science Today, since 2014 Editorial Board of Beverages ( ISSN (since 2013) Member of the Advisory Board: International Journal of Ayurveda & Alternative Medicine (IJAAM) (since 2013) Editor of the Peak Journal of Medicinal Plant Research (PJMPR) (since 2013) Member of the Editorial Board: Online international Journal of Food Science (since 2013) Editor of 'Advancement in Medicinal Plants and Alternative Medicine (AMPAM)' (since 2013) Member of the Editorial Board of ISRN Pain (since 2013) Editor of Advancement in Medicinal Plant Research (AMPR), (since 2013) Managing Editor Nutrition at WebmedCentral WMC (since 2013) Member of the Editorial Board the Journal Vitalstoffe (since 2012) Member of the Editorial Board: Journal Klinische Forschung und Recht, pmi Verlag (since 2007) Member of the Steering Committee for Nutraceutical Business & Technology (since 2006) Nutraceutical Business & Technology (Editorial Board) (since 2006) Integrative Medicine Insights (Associate Editor) (since 2005) Natural Standard (Senior Editorial Board) (since 2005) NutraCos (Editorial Committee) (since 2004) Journal of Herbal Pharmacology (Editorial Board) (since 2003) Evidence-Based Integrative Medicine (International Editorial Board) (since 2003) AgroFood Industry (Contributing Editor) (since 2003) Nutrafoods (Editorial Advisory Board) (since 2002) Nutraceuticals World (Contributing Editor) (since 2000) Fitomedicina Científica (Editorial Board) (since 1998) AHPA Report (European Correspondent) (since 1996) Advances In Natural Therapy, (Editor in Chief) ( ) Journal of Medicinal Food (Editorial Board) ( ) Nutrition Business Journal (European Editor) ( ) Recent and Future Presentations May 15 th, 2014, Innovations in Allergy Treatment, Round Table for Allergologists, Kiew, Ukraine May 7 th, 2014, Problems and Solutions with elderly in clinical trials, Vitafoods, Geneva, Switzerland March 17 th, 2014, Weight Management Expert Meeting, Natural Therapeutic Options in the Treatment of Obesity, KualaLumpur, Malaysia March 6, 2014, 2nd International Workshop Food, Nutrition & Health Claims Legislation in Europe, Anaheim CA, USA September 13, 2013, Congress of Obesity, Polish Society for the Study of Obesity, Litramine a safe and effective ingredient for the treatment of overweight and obese Patients, Zawiercie, Poland May 14,2013, Vitafoods Europe 2013, Vitafoods Reception Omniactive, EFSA Claims, Challenges and the way forwards, Geneva, Switzerland April 18, 2013, 4th international workshop Botanicals, Nutrients & Food Supplement Claims Europe, Brussels, Belgium September 25-26, 2012, Allergology + Immunology Interdisciplinary Tasks, Innovativ in allergy treatment, Kazan, Russia January 19, 2012, Health Claims Conference, Ljubljana, Slovenia December 8-9, 2011, Health Claims Substantiation, Designing Successful Clinical Studies, Brussels, Belgium August 26, 2011, Swiss Family Docs Conferenz, Basel, Switzerland CV Dez2014.docx 4 / 17

5 August 23, 2011, Roundtable Charité, Übergewicht in Deutschland, Neueste Erkenntnisse und Optionen des Gewichtsmanagements, Berlin, Germany April 14, 2011, Symposium on Investment & Business Opportunities in the Herbal Industry, Kuala Lumpur, Malaysia March 28-30, 2011, Workshop Capacity Building, Harare, Zimbabwe June 4, 2010, BB LIFE 2010, Kosmetische Mittel Anforderungen und Chancen, Berlin, Germany May 6, 2010, ICADA Fachtagung, Fankfurt, Germany 29 April, 2010, 5th Nutrition health claim conference, Bruessels, Belgium April 29, 2010, 5th International Workshop Nutrition & Health Claims Designing clinical studies for success, Brussels, Belgium April, 2010, International Fresenius Conference on Health and Nutrition Claims in Europe, Mainz, Germany January, 2010, Euroforum, Frankfurt am Main, Germany November 16-19, 2009, FI Europe, Frankfurt am Main, Germany October, 2009, Nutraceuticals & Functional Foods, London, UK October 6, th Interactive Workshop Nutrition & Health Claims Europe, Brussels, Belgium September 16-17, 2009, Fresenius Academy, Dortmund, Germany September 10-12, 2009, 7 th Berlin Congress Phytotherapy, Berlin Germany June 18, 2009, ESCOP Symposium, Cologne, Germany June 17-18, 2009, NutrEvent, Lille, France May 18-21, 2009, Bio2009 International Convention, Atlanta, USA May 4-6, 2009, Vitafoods, Geneva, Switzerland November 4 6, HI/NI Conference 2008, Paris, France September 11 12, 2008 Food & Drink Innovation Summit 2008, Prague, Czech Republic July 8-9, 2008, IFI Functional Food Forum, Amsterdam, Netherlands June 25 26, Slimming Ingredients 2008, Berlin, Germany June, 14 20, 2008, Bio 2008, San Diego, USA May 6-8, 2008: Vitafoods, Geneva, Switzerland April 28-29, 2008: SCS 2008 Cosmetic Science Symposium, Bristol, UK March 31-April 1: BASF Workshop 'Nutrition: Unmet Needs and Key Trends 2015', Ludwigshafen, Germany March 27 29, Asia Pacific Natural Products Expo (NATPRO), Kuala Lumpur, Malaysia Feb , 2008: Phytotherapie-Kongress Berlin, Germany Feb , 2008: Behr s Praxisforum Health Claim and Nutrition, Darmstadt, Germany Jan , 2008: Panacea Natural Products Expo, Mumbai, India Nov , 2007: WHAT Medicine Conference, Kuala Lumpur, Malaysia Oct. 10, 2007: First Kava Science Symposium, Hawaii Sep , 2007: Confectionery Conference, Leatherhead, London, UK July 28-Aug. 1, 2007: IFT Chicago, USA July 14-18, 2007: Chair and Speaker Annual Meeting American Society of Pharmacognosy, Portland, USA May 8-10, 2007: Speaker and Chair Cosmeceutical Session, Vitafoods, Geneva, Switzerland April 27, 2007: Speaker and Chair The Future of Nutraceuticals, Istanbul, Turkey Feb. 7, 2007: Wirkkosmetik fuer die Haut, IIR-Kongress, Munich, Germany December 13-14, 2006: Speaker and Chair at Regulations on Nutraceuticals, Brussels, Belgium November 28-29, 2006: Beauty from the inside out, London, UK November 17, 2006: Wiener Buchmesse, Vienna, Austria November 13, 2006: Sabinsa on Wheels, Sulzbach, Germany September 28-29, 2006: Phytotherapie Kongress, Berlin, Germany September 13, 2006: Functional Beverages, Leatherhead London, UK May 9-11, 2006: Speaker and Chair at Vitafoods, Geneva, Switzerland April 5-7, 2006: In-Cosmetics, Barcelona, Spain Feb. 28 Mar. 1, 2006: International Kava Conference, Suva, Fiji TV- and Radio-Interviews CV Dez2014.docx 5 / 17

6 Interview partner in over 100 TV- and 70 Radio shows in Germany (ZDF, RTL, SAT 1, 1A, SWF, SDR, WDR) Canada, (CBC, Canada 1, Canada Life) USA (CNN, ABC, CBS, NBC etc.) Switzerland (SR), Austria (ORF), United Kingdom (BBC), France, Italy, Spain, Sweden, Finland, Denmark, Holland, Belgium, Greece, Hungary, Israel, Australia, South Africa, Fiji, Tonga, Samoa 56 interviews for Focus TV Gesundheit (Focus Health), Mai 2005 Schulmedizin oder Naturheilkunde - Gesund durch den Herbst Weck-Up, Sat1, Okt Public funding of projects! Project 1: In-depth investigation into EU Member States market restrictions on Kava products (financed by CDE), 2003 Compilation of scientific background information to evaluate all available cases and scientific information on Kava, the restrictive measures taken against Kava by health authorities, and the resulting economic consequences Development of an argumentation chain and strategic action plan to rebut the ban on Kava in most European states! Project 2: financed by PRO INVEST (PAC/0302/00/CM) Organisation of an EU-ACP Kava Stakeholder Meeting in Brussels, August 2003! Project 3: financed by PRO INVEST (PAC/4108/01/CP) Implementation of policy proposals and lobby activities for the removal of the European ban imposed Kava from the pacific and increase investment in the Kava industry, 2004! Project 4: Capacity Building for the Southern African Natural Products Trade Association, financed by PRO INVEST (SAF/6355) Training of PhytoTrade Africa s staff and members to get knowledge about regulatory and quality requirements to access EU markets for their natural products (food and cosmetics), development of strategies how to position their products including competitor analysis, distribution channels, suitable marketing tools, etc. Two workshops were held in Harare, Zimbabwe.! Project 5: EU-ITN Application for HORIZON 2020 Low Weight Edible Plants Derived Protein as Modulators of Satiety and Carbohydrate Catabolism Publications Books and other media: 1. Gruenwald J, Jaenicke C, Hansen A: iphone/ipad App: Bach-Blüten, based on Quickfinder Bachblüten Gruenwald J, Jaenicke C, Hardewig I: iphone/ipad App: Heilpflanzenmittel, based on Quickfinder Pflanzenheilkunde, Gruenwald J, Jaenicke C: Grüne Apotheke (Griechische Ausgabe), Graefe & Unzer Verlag, München, Gruenwald, J., Jaenicke, C.: Alternativ heilen, Verlagsgruppe Weltbild, Augsburg Gruenwald, J., Jaenicke, C., Hardewig, I.: Se soigner par les plantes, Éditions Vigot, Paris Jaenicke, C., Gruenwald, J., Hansen A.M., Quickfinder Bach-Blüten, Graefe und Unzer Verlag GmbH, München, Gruenwald, J., Jaenicke, C., A farmácia verde, Everest Editora 2009, Portugal. 8. Gruenwald, J, Jaenicke, C, Alternativa medicina, Modrijan, Ljubljana Gruenwald, J., Management Report: Using Sustainable Ingredients in Food and Drinks, Business Insight Ltd, 2008 London 10. Bodeker, G., Jaenicke,C., Gruenwald, J., et. al, Health and Beauty from the Rainforest, Mailaysian Traditions of Ramuan, EDM Malaysia, Gruenwald, J., Management Report Switching to Natural Food and Drink Igredients, Business Insight Ltd., 2009, London. 12. Gruenwald, J., Jaenicke, CL Alternativ Heilen (VIndecarea alternativâ), Vesna Virant, Mlladinska CV Dez2014.docx 6 / 17

7 13. Gruenwald J, Jaenicke C: Zelená lékárna, Svojtka & Co, Prag Gruenwald J, Jaenicke C: Zöldpatika, Mérték Kiadó, Budapest Gruenwald J, Jaenicke C, Hardewig I: Quickfinder Pflanzenheilkunde, Bertelsmann Club Ausgabe, Gruenwald J: Management Report on Future Functional Ingredients: Novel applications, emerging R&D and new product opportunities, Business Insights Ltd London, 2008, 17. Gruenwald J, Jaenicke C, Hardewig I: Quickfinder Pflanzenheilkunde, Graefe & Unzer Verlag, München, Gruenwald J, Jaenicke C: Alternativ heilen, Bertelsmann Verlag, Bielefeld, Gruenwald J, Jaenicke, C: La santé par les plantes, Marabout, Paris, Jaenicke C, Gruenwald J: Alternativ heilen, Graefe & Unzer Verlag, München, Gruenwald J, Fischer-Reska, H: Pflanzenheilkunde Das DVD Lexikon der Heilkräuter, Focus Gesundheit, Gruenwald J, Jaenicke C: De Groene Apotheek, Deltas Aartselar, Gruenwald J, Jaenicke C: Guide de la Phytothérapie, Marabout Paris, Gruenwald J, Jaenicke C: Zelena Ljekarna, Mozaik knjiga, Zagreb, Gruenwald J, Jaenicke C: Zelena lekarna, Mladinska knjiga, Ljublijana, Gruenwald J, Jaenicke C: Grüne Apotheke, Graefe & Unzer Verlag, München, Jaenicke C, Gruenwald J, Brendler T,: Handbuch für Phytotherapie, Wissenschaftliche Verlagsgesellschaft Stuttgart, Gruenwald J, Jaenicke C, Brendler T, Smith E,: Plant-based Ingredients for Functional Foods, Leatherhead Publishing Gruenwald J, Brendler T, Jaenicke C, Scientific Editors: The PDR Family Guide to Natural Medicines & Healing Therapies, Medical Economics Company, Gruenwald J, Brendler T, Jaenicke C, Scientific Editors: Physicians Desk Reference (PDR) for Herbal Medicines, Thomson/Medical Economics Company, Montvale 1998 (1 st ) and 2004 (3 rd edition), 2008 (4 th edition) 31. Blumenthal M, Busse W R, Goldberg A, Gruenwald J, et al.: Editors, The Complete German Commission E Monographs, American Botanical Council, Gruenwald J: Natürlich durch die Wechseljahre, Kabel-Verlag Hamburg, Gruenwald J, Brendler T, Jaenicke C, Editors: CD-ROM Heilpflanzen - Herbal Remedies, 1 st through 5 th edition, Medpharm Stuttgart, Articles: 1. Gruenwald, J., Wohlfarth I., The botanical situation in Europe, AHPA Report Vol.29, Number 11, Nov Gruenwald, J., Wohlfarth I., Customizing Your clinical Trial to 'Silvers', The World of Food Ingredients, Sept Gruenwald, J., Carbohydrates & Health: A European View on Obesity, Nutraceuticals World Sept Chong P., Lau K., Gruenwald, J., Uebelhack, R., Review of the Efficacy and Safety of Litramine IQP-G- 002AS, an Opuntia ficus-indica Derived Fiber for Weight Management, Evidence-Based Complementary and Alternative Medicine, Volume Gruenwald, J., Wohlfarth I., Health claim applications with EFSA startegies and points to consider. In: Innovation in Food technology, May Gruenwald, J., Health Claim Approved: Still Not Out Of The Woods, Nutraceuticals World March/Apr Gruenwald, J., The End of Botanical Supplements in the U.K.? Nutraceuticals World Jan/Feb Gruenwald, J., Notes on Novel Foods, Safety assessments are essential for manufacturers in order to market new ingredients successfully, Nutraceuticals World Nov Gruenwald, J., Navigating the Claims Maze, Despite the rather dismal ratio of approved vs. Unapproved health claim applications, it is possible to win a claim..., Nutrition Insight Holz, C., Alexander, C., Balcke, C., Moré, M., Auinger, A., Bauer, M., Junker, L., Gruenwald, J. et al, Lactobacillus paracasei DSMZ16671 Reduces Mutans Streptococci: A Short-Term Pilot Study, Probiotics & Antimicro. Prot., DOI /s , Sep Gruenwald, J., Riede L., Grube B. (2013), Larch arabinogalactan effects on reducing incidence of upper respiratory infections, Current Medical Research & Option, Vol. 29 Number 3, Gruenwald, J.(2013), European Health Claim Regulation Takes Effect, Nutraceuticals World Jan Guay, J., Champagne, P., Guibord, P., Gruenwald, J. (2012), The Efficacy and Safety of a Patent Pending CV Dez2014.docx 7 / 17

8 Combination of Ginger and Goldenrod Extracts on the Management of Cold Symptoms: A Randomized, Double-Blind Controlled Trial, Food and Nutrition Sciences, 2012, 3, Gruenwald, J.(2012), Wissensriesen-Umsetzungszwerge, E&M-Ernährung und Medizin 2012, 27: Gruenwald, J.(2012), European Health Claim Evaluations for Botanical On Hold, Nutraceuticals World Nov. 2012; Gruenwald, J.(2012), Ist Knoblauch wirklich so gesund?, Gruenwald, J.(2012), Eurotrends: Unhealthy Food Tax: A Viable Solution?, Nutraceuticals World Jan Gruenwald, J., Stier, H.,Bruhn, S.,Goyvaerts, B., Rhodiola rosea: ein Adaptogen bei Burn-out, Zeitschrift für Phytotherapie 2011; 32: Gruenwald, J.(2011), Regulatory Climate in Europe Moves Closer Towards Harmonization, Nutrition Business Journal Nov/Dec 2011: Gruenwald, J., Armbruester, N.,Schaudt, M.(2011), Wissenschaftlich belegt: Cefavora memo reduziert chronischen Stress, Beilage DBI Der Bayerische Internist 6/11, Dez Gruenwald, J.(2011), The future of botanicals in health products, Nutrafoods 22. Gruenwald, J.(2011), Aktuelle Trends in der Behandlung von Übergewicht, der Sept Gruenwald, J.(2011) Chronic inflammation and how it affects the European supplements industry, Nutraceuticals World Aug Gruenwald, J.,Stier, H., Bruhn, S.,Goyvaerts, B., Rhodiola rosea: ein Adaptogen bei Burn-out, Zeitschrift für Phytotherapie 2011; 32: Gruenwald, J.(2011) The European Health Claim Regulation: Getting the most out of Article 13.1 claims, Nutraceuticals World Mai Gruenwald, J.(2011) The European Health Claim Regulation: EFSA decisions that make you go 'huh?', Nutraceuticals World März, Gruenwald, J.(2011) Update on EU health claim situation: More rejections in latest batch of generic claims, Nutraceuticals World Feb Gruenwald, J.(2010) Novel Food Regulation in Europe - Status Quo, Wiggle Room, and Upcoming Changes, Nutraceuticals World Okt Gruenwald, J.(2010) Glucosamine and health claims in Europe - a case study proving that it is worth to fight back, Nutraceuticals World Aug Gruenwald, J.(2010) Nutricosmetics - New Trends, Nutraceuticals World Mai, Gruenwald, J., Schmidt, M., Klosterfrau Melissengeist hilft bei Wetterfühligkeit ;Journal für die Apotheke; (5)2010: S Gruenwald, J., Busch, R., Graubaum, H-J., Schmidt, M., Double-blind comparison of two types of benzocaine lozenges for the treatment of acute pharyngitis, Arzneimittelforschung/ Drug Research 2010; 60(5): Gruenwald, J.,Freder, J.,Armbruester, N.,Cinnamon and Health, Critical Reviews in Food Science and Nutrition, 50: (2010) 34. Luond-Valeskeviciute, I., Haenggi, B., Gruenwald,J.: Efficacy Of Three Thixotropic Nasal Spray Preparation On Seasonal Allergic Rhinitis Assessed By Allergen Challenge In An Environmental Exposure Unit, WebmedCentral ALLERGY 2010;1(10):WMC Gruenwald, J. (2010) Do your clinical trials meet EFSA s health claim standards?, Nutraceuticals World April, Gruenwald, J., Schütz, K., Saß, M., de With, A., Graubaum, H-J., (2010) Immune-modulating efficacy of a polyphenol-rich beverage on symptoms associated with the common cold: a double-blind, randomised, placebocontrolled, multi-centric clinical study., British Journal of Nutrition (2010), April, p Jörg Grünwald, Norman Bitterlich, Christian, Nauert, Mathias Schmidt, Anwendung und Verträglichkeit von Beinwellcreme (Symphyti herba) bei Kindern mit aktuen stumpen Traumen, Zeitschrift für Phytotherapie 2010; 31: Gruenwald, J. (2010) Exotic botanicals with historical tradition offer significant potential for product development, Nutraceuticals World Jan., Gruenwald, S. Moenke-Liebig, J. Hansen, Wirkung und Verträglichkeit von Klosterfrau Melissengeist bei der Behandlung von Befindlichkeitsstörungen im Sinne eines Burnout-Syndroms, Journal Pharmakol. U. Ther. 5/2009, 18.Jg 40. Gruenwald, J. (2009) The European regulatory system will force many existing products to drop health claims from their labels and other advertising, Nutraceuticals World Nov., Gruenwald, J. (2009) More than half of consumers heavily consider sustainability when buying products, Nutraceuticals World Sep., Gruenwald, J., Hoie, L.M., Stier, H., Cardiovascular Benefits of Soy Supplements, Integrative Medicine, p. 30, Vol. 8, No. 4, Aug./Sept Gruenwald, J. (2009) Alles, nur nicht zweite Wahl Interview f. Zeitschrift Prisma, S. 6. CV Dez2014.docx 8 / 17

9 44. Gruenwald, J., (2009) Natural and Efficacious, The World of Food Ingredients, p Gruenwald, J., (2009) Novel botanical ingredients for beverages, Elsevier, Clinics in Dermatolog, 27, p Gruenwald, J., (2009) Fortification of beverages with products otherthan vitamins and minerals, Functional and speciality beverage technology, ed. By Paul Paquin, Woodhead Publishing; Food and Science, p Gruenwald, J. (2009) Prophylactic and Therapeutic Effect of 1,5-Pentanediol for Herpes Simplex Labialis a placebo-controlled Clinical Trial, Advances in Therapy 8, Gruenwald, J., Graubaum, H-J, Busch, R., Petzold H-P. (2009) Effect of Glucosamine Sulfate with or without Omega-3 Fatty Acids in Patients with Osteoarthritis, Advances in Therapy, March Gruenwald, J. (2009) New science continues to emerge in support of old spices, Nutraceuticals World June, Gruenwald, J. (2009) The trend away from artificial ingredients and toward exotic ingredients has fueled demand for natural ingredients, Nutraceuticals World April, Gruenwald, J. (2009) What does your company need to know in order to get a health claim through the approval process?, Nutraceuticals World Jan., Gruenwald, J. (2008) Solutions for Overweight - The World of Food Ingredients, p Dec, Gruenwald, J. (2008) The new health claims process; In its first round of evaluations, EFSA refuses eight of nine health claim submissions,. Nutraceuticals World Nov, Biller, A., J. Gruenwald, et al. (2008). 'Wirksamkeit und Verträglichkeit eines Rhodiola-rosea-Extracts bei älteren Erwachsenen mit verminderter Körperlicher und geistiger Vitalität.' Zeitschrift für Phytotherapie 29(Suppl 1): S Gruenwald, J. (2008). 'Functional Beverage Trends.' Nutraceuticals World: Gruenwald, J. (2008). 'Europe: Substantiation of proprietary food claims needed.' Nutraceuticals World. 57. Gruenwald, J. (2008). 'Opportunities for international herbal products to come to the European Markets.' Nutraceuticals World. 58. Gruenwald, J. (2008). 'The Global Herbs & Botanicals Markets.' Nutraceuticals World. 59. Gruenwald, J. and B. Grube (2008). 'Wirkung und Verträglichkeit des Homöopathikums aus Adhatoda vasica bei Patienten mit Hausstaubmilbenallergie.' EHK 57: Gruenwald, J. and I. Wohlfahrt (2008). 'Overview of the European market of slimming ingredients.' Agro Food Industry hi-tech 18(5): Grünwald, J. and R. Busch (2008). 'Wirkung und Verträglichkeit von Melissa officinalis bei Wechseljahresbeschwerden.' EHK 57: Grünwald, J., C. Staiger, et al. (2008). 'Wirksamkeit einer Beinwell-Salbe bei Patienten mit Osteoarthritis des Kniegelenks: Ergebnisse einer doppelblinden, randomisierten, bizentrischen, placebokontrollierten Studie.' Zeitschrift für Phytotherapie 29(Suppl 1): S Armbrüster, N. and J. Grünwald (2008). 'Marktchancen für Phytopharmaka.' Zeitschrift für Arznei- & Gewürzpflanzen 13(2): Grube, B., J. Gruenwald, et al. (2007). 'Efficacy of a comfrey root (Symphyti offic. radix) extract ointment in the treatment of patients with painfull osteoarthritis of the knee: Results of a double-blind, randomised, bicenter, placebo-controlled trial.' Phytomedicine 14(1): 1-10 (Reprint). 65. Gruenwald, J., (2007), Contribution of Pharmacognosy to Clinical Trials of Botanicals and Dietary Supplements, The Journal of Alternative and Complementary Medicine 66. Gruenwald, J., C. Bentley, et al. (2007). 'Adhatoda vasica hemmt dosisabhängig allergische Mechanismen.' Natura Med 22(3): Gruenwald, J., (2007). La radiation des produits à base de kava du marché européen: une leçon pour tous les phytomédicaments, La phytothérapie européenne 68. Gruenwald, J., (2007). Germany and Sweden: Regulation of Functional Foods and Herbal Products, Regulation of Functional Foods and 69. Gruenwald, J. and C. Bentley (2007). 'Chininsulfat als Baustein der Fibromyalgiebehandlung.' Der Heilpraktiker & Volksheilkunde 9: Gruenwald, J. and R. Busch (2007). 'Einsatz von Klosterfrau Melissengeist bei grippalen Infekten.' Zeitschrift für Phytotherapie 28: Gruenwald, J., H.-J. Graubaum, et al. (2007). 'Thymian und Primelwurzel - ein starkes Doppel gegen Bronchitiden.' Erfahrungsheilkunde 56: Gruenwald, J. and I. Wohlfahrt (2007). 'Kava - Eine Lektion für alle pflanzlichen Arzneimittel.' (phytopherapie) 7(3): Hoie, L., M. Guldstrand, et al. (2007). 'Cholesterol-Lowering Effects of a New Isolated Soy Protein With High Levels of Nondenaturated Protein in Hypercholesterolemic Patients.' Advances in Natural Therapie 24(2): Wienecke, E. and J. Gruenwald (2007). 'Nutritional Supplementation: Is It Necessary for Everybody?' Advances in Therapie 24(3): CV Dez2014.docx 9 / 17

10 75. N., N. (2007). 'Thymianfluidextrakt gegen Husten.' Naturamed 22(11). 76. Gruenwald, J., H. Graubaum, et al. (2006). 'Safety and Tolerance of Ester-C Compared With Regular Ascorbic Acid.' Advances in Therapy 23(1): Gruenwald, J. and M. Schmidt (2006). 'Steigerung der kognitiven und physischen Leistungsfähigkeit mit Cholin und Deanol.' Journal für Orthomolekulare Medizin 14(2): 1-9 (Sonderdruck). 78. Uebelhack, R., J.-U. Blohmer, et al. (2006). 'Black Cohosh and St. John's Wort for Climacteric Complaints. A Randomized Trial.' Obstetricians and Gynecologists 107(2, Part 1): Brendler, T., J. Gruenwald, et al. (2006). 'Devil's Claw (Harpagophytum procumbens DC): An Evidence-Based Systematic Review by the Natural Standard Research Collaboration.' J Herb Pharmacother 6((1)): Gruenwald, J. (2006). 'Anti-ageing nutraceuticals.' FS&T 20(3): Gruenwald, J. (2006). Facteurs réduisant les coûts de la santé en phytothérapie, à l'exemple du Ginkgo biloba et du millepertuis, La phytothérapie européenne 82. Gruenwald, J., H.-J. Graubaum, et al. (2006). 'Evaluation of the Non-inferiority of a Fixed Combination of Thyme Fluid- and Primrose Root Extract in Comparison to a Fixed Combination of Thyme Fluid Extract and Primrose Root Tincture in Patients with Acute Bronchitis.' Arzneimittel-Forschung/Drug Research 56(8): Gruenwald, J., H.-J. Graubaum, et al. (2006). 'Osteoporose-Prophylaxe und Minderung rheumatischer Beschwerden durch eine Mineralstoff- und Vitaminkombination.' Ernährung & Medizin 21: Ulbricht, C., T. Brendler, et al. (2006). 'Lemon Balm (Melissa officinalis L.): an Evidence-Based Systematic Review by the Natural Standard Research Collaboration.' Journal of Herbal Pharmacotherapy 5(4). 85. Gruenwald, J., H.-J. Graubaum, et al. (2006). 'Anwendungsbeobachtungen zur Phytotherapie bei Kindern mit akuter Bronchitis.' päd 12(5): Gruenwald, J., H.-J. Graubaum, et al. (2006). 'Thymian und Primelwurzel - ein starkes Doppel gegen Bronchitiden.' Phytotherapie 27: Gruenwald, J., H. Palissa, et al. (2006). 'Beleg der Kinderdosierung (1-11 Jahre) durch Anwendungsbeobachtung mit Tussamag Hustensaft N bei akuter Bronchitis.' Kongressband Phytotherapie 27: S Hoie, L., A. Sjoholm, et al. (2006). 'Ultra heat treatment destroys cholesterol-lowering effect of soy protein.' International Journal of Food Sciences and Nutrition 57(7/8): Fiebich, B., and J. Grünwald. (2006). 'Synergistische Effekte von Glucosaminsulfat und Chondroitinsulfat: Eine Invitro-Untersuchung.' Journal für Orthomolekulare Medizin 14: Gruenwald, J., and C. Bentley. (2006). 'Wirkung von Chininsulfat bei Fibromyalgie in Anwendungsbeobachtung bestätigt.' Orthopädie & Rheuma 9: Gruenwald, J. (2005). 'International Kava Conference Held in Fiji: Attendees Request Removal of All International Restrictions for Kava.' Herbalgram 66: Hoie, L., H. Graubaum, et al. (2005). 'Lipid-Lowering Effect of 2 Dosages of a Soy Protein Supplement in Hypercholesterolemia.' Advances in Therapy 22(2): Gruenwald, J. (2005). 'Phytopharmakon reduziert Unruhe, Nervosität und Stresssymptome.' NaturaMed 20(8): Gruenwald, J., H. Graubaum, et al. (2005). Klinische Studien bestätigen die Wirkung flüssiger Darreichungsformen einer Kombination von Thymian und Primula bei Erwachsenen mit akuter Bronchitis. Phytopharmaka und Phytotherapie 2005: Graubaum, H. and J. Gruenwald (2005). Burteilung der Wirkung und Verträglichkeit von Klosterfrau Allergin (Adhatoda vasica) bei der Behandlung der saisonalen allergischen Rhinitis: eine Anwendungsbeobachtung. Phytopharmaka und Phytotherapie 2005: Nauert, C., J. Gruenwald, et al. (2005). Wirksamkeit und Verträglichkeit flüssiger Darreichungsformen einer fixen Kombination von Thymian und Primula (T+P) bei Kindern mit akuter Bronchitis. Phytopharmaka und Phytotherapie 2005: Nauert, C., C. Bentley, et al. (2005). In vitro Untersuchungen zur muolytischen Wirkung einer fixen Kombination von Thymian und Primula (T+P). Phytopharmaka und Phytotherapie 2005: Gruenwald, J., H. Graubaum, et al. (2005). 'Efficacy and Tolerability of a Fixed Combination of Thyme and Primrose Root in Patients with Acute Bronchitis.' Arzneimittel-Forschung/Drug Research 55(11): Gruenwald, J., H.-J. Graubaum, et al. (2005). 'Wirksamkeit und Verträglichkeit eines Kombinationspräparates aus Thymian und Primelwurzel bei Patienten mit akuter Bronchitis.' Arzneimittel-Forschung/Drug Research 55(11): Gruenwald, J. (2005). 'Hoodia: Business Opportunity or Dangerous Business?' Nutraceuticals World(09): Ulbricht, C., T. Brendler, et al. (2005). 'Lemon Balm (Melissa officinalis L): An Evidence-Based Systematic Review by the Natural Standard Research Collaboration.' Journal of Herbal Pharmacotherapy 5(4): Gruenwald, J. and C. Mueller (2005). 'Reviewing Vitamin E.' Nutraceuticals World: Gruenwald, J. (2005). 'Safety & Efficacy of Kava Re-confirmed.' Nutraceuticals World: Gruenwald, J. (2005). 'Garlic Revival.' Nutraceuticals World: 28 CV Dez2014.docx 10 / 17

11 105. Gruenwald, J. (2005). 'Weight Loss Supplements.' Nutraceuticals World: Gruenwald, J. and J. Skrabal (2004). 'WHO To Re-Evaluate Kava.' Nutraceuticals World 1/2: Gruenwald, J. (2004). 'The tale of the little fish that dared to swim in a big pond.' Functional Foods & Nutraceuticals(3): Gruenwald, J. (2004). 'Kava Stakeholders Plan Regulatory Review and Market Return.' HerbalGram 61: Gruenwald, J. and C. Müller (2004). 'The European Market.' Nutraceuticals World 3: Editors, T. (2004). 'Market Restrictions on Kava Products.' Nutrafoods 3(1): Gruenwald, J. (2004). 'EU Market Changes: Challenges & Opportunities.' Nutraceuticals World 4: Gruenwald, J. and J. Skrabal (2004). 'International Kava Executive Council in Berlin and London March 31 through April 3, 2004.' Natural 1 May: Gruenwald, J. and J. Skrabal (2004). 'International Kava Execiutive Council' a Berolino e Londra.' Natural 1: Gruenwald, J. and J. Skrabal (2004). 'Breakthrough In Kava Debate.' Nutraceuticals World 6: Uebelhack, R., J. Gruenwald, et al. (2004). 'Efficacy and Tolerability of Hypericum Extract STW 3-VI in Patients With Moderate Depression: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.' Advances in Therapy 21(4) Gruenwald, J. (2004). 'The European Herbal Market Is Growing Again.' Nutraceuticals World 11: Gruenwald, J. and S. Spiess (2004). Motives of Conducting Clinical Trials on Botanicals in Europe: A Focus on Germany. The Handbook of Clinical Tested Herbal Remedies. M. Barrett, The Haworth Herbal Press Pharmaceutical Products Press The Haworth Medical Press. 1: Hoie, L., E. Morgenstern, et al. (2004). 'A double-blind placebo-controlled clinical trial compares the cholestollowering effects of two different soy protein preparations in hypercholeserolemic subjects.' European Journal of Nutrition(Online first): Gruenwald, J., H. Graubaum, et al. (2004). 'Efficacy and Tolerability of a Combination of Lyprinol and High Concentrations of EPA and DHA in Inflammatory Rheumatoid Disorders.' 21(3): Gruenwald, J., H. Graubaum, et al. (2004). 'Rheumatische Beschwerden: AWB bestätigt Effizienz von Vitamin E.' NaturaMed 19(11): Gruenwald, J. and C. Mueller (2003). 'Opportunities For High-Dosage Products In Europe.' Nutraceuticals World 1-2: Hermansen, K., B. Dinesen, et al. (2003). 'Effects of Soy and Other Natural Products on LDL: HDL Ration and Other Lipid Parameters: A Literature Review.' Advances In Natural Therapy 20(1): Herzberg, F. and J. Gruenwald (2003). 'Aloe Vera: An International Success Story.' Nutraceuticals World(May): Gruenwald, J., C. Jaenicke, et al. (2003). 'Lycopene - The modern answer to urban wellness?' Nutrafoods 2(1): Gruenwald, J. and C. Müller (2003). 'The European Herbal & Natural Products Market.' Nutraceuticals World 4: Gruenwald, J. and C. Müller (2003). 'Opportunities For High-Dosage Products In Europe.' Nutraceuticals World 1/2: Gruenwald, J. (2003). 'Proprietary Soy Products From Europe.' Nutraceuticals World 1/2: Gruenwald, J. (2003). The Namibian national devil's claw situation analysis, CRIAA SA-DC 129. Zunft, H., W. Lüder, et al. (2003). 'Carob pulp preparation rich in insoluble fibre lowers total and LDL cholesterol in hypercholesterolemic patients.' Eur J Nutr 42: Gruenwald, J. (2003). 'Rebuilding The Market.' Nutraceuticals World 9: Galizia, M. and J. Gruenwald (2003). 'Markt und Marketing von Fertigprodukten aus Arzneipflanzen und die Deckung des Rohwarenbedarfs.' Zeitung für Arzneimittel und Gewürzpflanzen 8(3): Gruenwald, J. and J. Skrabal (2003). 'The Kava Executive Committee.' Nutraceuticals World 11: Gruenwald, J. and C. Mueller (2003). 'Kava Update.' Nutraceuticals World 6: Gruenwald, J. and J. Skrabal (2003). 'Kava Ban Highly Questionable: A Brief Summary of the Main Scientific Findings Presented in the 'In Depth Investigation on EU Member States Market Restrictions on Kava Products'.' Seminars in Integrative Medicine 1(4): Gruenwald, J. (2002). The regulation of botanicals as drugs and dietary supplements in Europe. Advances in Phytomedicine - Ethnomedicine and Drug Discovery. M. Iwu and J. Wootton. Amsterdam, Elsevier Science B.V. 1: Gruenwald, J. (2002). 'The Future Of Herbal Medicines In Europe.' Nutraceuticals World 6: Gruenwald, J. (2002). 'Plant-Based Ingredients for Functional Foods.' Nutraceuticals World 11: Behnke, K., G. Jensen, et al. (2002). 'Hypericum Perforatum Versus Fluoxetine in the Treatment of Mild to CV Dez2014.docx 11 / 17

12 Moderate Depression.' Advances in Natural Therapy 19(1): Gruenwald, J., H. Graubaum, et al. (2002). 'Effect of Cod Liver Oil on Symptoms of Rheumatoid Arthritis.' Advances in Natural Therapy 19(2): Gruenwald, J. (2002). 'HRT Alternatives.' Nutraceuticals World 9: Gruenwald, J. and J. Freder (2002). 'Kava: The Present European Situation.' Nutraceuticals World 1-2: Gruenwald, J., C. Jaenicke, et al. (2002). 'Lycopin.' Deutsche Apotheker Zeitung 142(8): Gruenwald, J. (2002). 'International Kava Alliance.' Nutraceuticals World 4: Gruenwald, J. and F. Herzberg (2002). 'The situation of major dietary supplements markets.' NutraCos 5-6: Gruenwald, J., H. Graubaum, et al. (2002). 'Effect of a Probiotic Multivitamin Compound on Stress and Exhaustion.' Advances in Natural Therapy 19(3): Gruenwald, J. and F. Herzberg (2002). 'The Global Nutraceuticals Market.' Business Briefing: Innovative Food Ingredients: Gruenwald, J., T. Brendler, et al. (2002). Plant-based ingredients for functional foods, Leatherhead Publishing Gruenwald, J., C. Jaenicke, et al. (2002). 'Das 'Supercarotinoid' Lycopin.' Ernährungsmedizin 2: Zunft, H., W. Lüder, et al. (2002). 'Influence of Two Different Soy Protein Supplements (Abacor forte and Supro Soy) on the Lipid Profiles.' Bast, A., R. Chandler, et al. (2002). 'Botanical health products, positioning and requirements for effective and safe use.' Environmental Toxicology and Pharmacology 12(4): Gruenwald, J. (2001). 'St. John's Wort - The International Debate.' Nutraceuticals World 6: Gruenwald, J., C. Jaenicke, et al. (2001). 'European View: Lessons American Herbal Marketers Should Learn.' Nutrition Business Journal 3: Gruenwald, J. and J. Freder (2001). 'Functional Drinks And Sports Nutrition.' Nutraceuticals World 11: Zunft, H., W. Lueder, et al. (2001). 'Carob Pulp Preparation for Treatment of Hypercholesterolemia.' Advances in Natural Therapy 18(5): Gruenwald, J. and J. Freder (2001). 'Lycopene - The most natural nutraceutical.' Food Today: Pelka, R., C. Jaenicke, et al. (2001). 'Impulse Magnetic-Field Therapy for Migraine and Other Headaches: A Double-Blind, Placebo-Controlled Study.' Advances in Therapy 18(3): Pelka, R., C. Jaenicke, et al. (2001). 'Impulse Magnetic-Field Therapy for Insomnia: A Double-Blind, Placebo- Controlled Study.' Advances in Therapy 18(4): Pelka, R., C. Jaenicke, et al. (2001). 'Impulse Magnetic-Field Therapy for Erectile Dysfunction: A Double-Blind, Placebo-Controlled Study.' Advances in Therapy 19(1): Gruenwald, J. (2000). 'Analyzing Botancical Safety Concerns.' Nutraceuticals World 1-2: Gruenwald, J. and A. Pearl (2000). 'The European Approach To Functional Foods.' Nutraceuticals World 10: Gruenwald, J. (2000). 'The Supplement Markets In The U.S. And Europe.' Nutraceuticals World 7-8: Pearl, A. and J. Gruenwald (2000). 'The definition of Nutraceuticals in the 21st century.' Food Today: Gruenwald, J. (2000). 'European Herbal Market Update.' Nutraceuticals World 4: Gruenwald, J., T. Brendler, et al. (2000). PDR for Herbal Medicines, Medical Economics Company Gruenwald, J. (1999). 'The Herbal Market Comes of Age.' The APHA Report 9-10: Gruenwald, J. (1999). 'Winners & Losers of Market Consolidation.' Nutraceuticals World 9-10: Gruenwald, J. (1999). 'The Market and Legal Status of Echinacea Products in Europe.' The APHA Report 5-6: Gruenwald, J. (1999). 'The International Herbal Medicine Market.' Nutraceuticals World 1-2: Gruenwald, J., T. Brendler, et al. (1999). The PDR Family Guide to Natural Medicines. Montvale, New Jersey, Medical Economics Company Gruenwald, J. (1999). 'The World Market For Hypericum Products.' Nutraceuticals World 5-6: Gruenwald, J. (1999). 'European Activities in the Field of Botanicals.' Drug & Market Development Gruenwald, J. (1999). 'The Regulation of Botanicals as Drugs & Dietary Supplements in Europe.' Regulatory Affairs Focus 11: Gruenwald, J., E. Langner, et al. (1998). The World Market of Hypericum Products. Medicinal And Aromatic Plants - Industrial Profiles, Vol Hypericum Gruenwald, J. (1998). Commercial & Industrial Aspects in the European Market. Medicinal And Aromatic Plants - Industrial Profiles, Vol Allium Sativum Gruenwald, J. (1998). 'A European Look at the American Herbal Industry.' The APHA Report 2(5): Gruenwald, J. (1998). 'Herbals Sales Close to $17 Billion Worldwide.' Nutrition Business Journal 1: Gruenwald, J. (1998). 'Herbal Tradition and Pharmaceutical Savvy-One View of the 21 st Century Herbal Products CV Dez2014.docx 12 / 17

13 Industry.' The APHA Report 2(4): Gruenwald, J. (1998). 'Saw Palmetto as an Accepted Prostatic Herbal Remedy in Europe.' The APHA Report 2(3): Gruenwald, J. (1998). 'Standardized Black Cohosh (Cimicifuga) Extract Clinical Monograph.' Quarterly Review of Natural Medicine 4: Gruenwald, J. and E. Langner (1998). Phytopharmaka im Internet. Phytopharmaka IV. Forschung und klinische Anwendung. Loew and Rietbrock. Darmstadt, Steinkopf: Gruenwald, J. (1998). 'The Emerging Role of Herbal Medicine in Health Care in Europe.' Drug Information Journal 32(1): Blumenthal, M., A. Goldberg, et al. (1998). German Commission E Monographs. Austin, Texas, American Botanical Council Langner, E. and J. Gruenwald (1998). 'Phytopharmaka im Internet.' Deutsche Apotheker Zeitung 138(29): Langner, E., S. Greifenberg, et al. (1998). 'Ginger: History and Use.' Advances in Natural Therapy 15(1): Gruenwald, J. (1998). 'Introduction.' Advances in Natural Therapy 15(2): Gruenwald, J. (1998). 'Opportunities for US Herbal Companies in Europe.' AHPA Report 1-2: Gruenwald, J. (1997). 'The World Market of Hypericum.' Nutraceuticals World 5-6: Langner, E., S. Greifenberg, et al. (1997). 'Ingwer.' Balance: Gruenwald, J. (1997). 'Qualitätskriterien für Knoblauchpräparate.' Naturamed 12: Gruenwald, J. (1997). 'Standardized St. John's Wort Extract Clinical Monograph.' Quarterly Review of Natural Medicine 3: Gruenwald, J. and A. Goldberg (1997). 'The Herbal Remedies Market in the US. Market development, consumers, legislation and organizations.' Drugs made in Germany 40(3): Gruenwald, J. (1997). 'Learning from the European Herbal Community.' The APHA Report 1(5): Yuan, R. and J. Gruenwald (1997). 'Germany Moves to the Forefront of the European Herbal Medicine Industry.' Genetic Engineering News 17: 14, Gruenwald, J. and A. Goldberg (1997). 'Der Markt pflanzlicher Heilmittel in den USA. Marktentwicklung, Verwender, Gesetzgebung und Organisationen.' Die Pharmazeutische Industrie 59(6): Gruenwald, J. (1997). 'Europe Leads in Herbal Remedies.' Nutrition Business Journal 1(1/2): Gruenwald, J. (1997). 'German Medicine Market Segments With a High Share of Phytotherapeutics.' Herbalgram 39: Orekov, A. and J. Gruenwald (1997). 'Effects of Garlic on Atherosclerosis.' Nutrition 13: Gruenwald, J. and K. Büttel (1996). 'Der europäische Markt für Phytopharmaka. Zahlen, Trends und Analysen.' Die Pharmazeutische Industrie 58(3): Gruenwald, J. and K. Büttel (1996). 'The European Phytomedicines Market - Figures, Trends, Analyses.' Drugs made in Germany 39: Gruenwald, J. (1996). 'The European Phytomedicines Market - Figures, Trends, Analyses.' Herbalgram 34: Almeida Santos, O. and J. Gruenwald (1993). 'Effect of garlic powder tablets on blood lipids, blood pressure and well being. A placebo-controlled double-blind study.' Br J Clin Res 4(37-44) Gruenwald, J., V. Schulz, et al. (1993). Knoblauch - Eine antiarteriosklerotische Naturarznei? Diätetik und Arteriosklerose. H. Heinle, H. Schulte and H. Schaefer, Vieweg Verlag, Braunschweig/Wiesbaden: Beck, E. and J. Gruenwald (1993). 'Allium sativum in der Stufentherapie der Hyperlipidämie.' Med Welt 44: Woelk, H., G. Burkhard, et al. (1993). 'Nutzen- und Risikobewertung des Hypericum-Extraktes LI 160 auf der Basis einer Drug-Monitoring-Studie mit 3250 Patienten.' Nervenheilkunde 12: Gruenwald, J. (1992). 'Knoblauch - Cholesterinsenkende Wirkung doppelblind nachgewiesen.' Deutsche Apotheker Zeitung 132: Gruenwald, J. (1992). 'Schützen Knoblauch-Präparate vor Arteriosklerose?' Ärztl Prax 69: Gruenwald, J., C. Fassold, et al. (1992). Allii sativi bulbus (Knoblauchzwiebel). Naturheilverfahren. F. Kemper and M. Bühring, Springer Verlag: Gruenwald, J., J. Heede, et al. (1992). 'Effects of garlic powder tablets on blood lipids and blood pressure - The Danish multicenter Kwai study.' Eur J Clin Res 3: Phelps, S., W. Harris, et al. (1992). 'Garlic Supplementation reduces the suspectibility to oxidation of LDLs.' Eur J Clin Res 3a: Schmidt, U. and J. Gruenwald (1992). 'Comparison of the lipid-lowering efficacy of a garlic powder preparation with that of a synthetic lipid-lowering agent.' Eur J Clin Res 3a: Schulz, V., D. Laudahn, et al. (1992). 'Johanniskraut als Antidepressivum.' Der Informierte Arzt/Gazette Medicale 19: CV Dez2014.docx 13 / 17

14 212. Gruenwald, J. (1991). 'Ginkgo biloba bei Hirnleistungsstörungen. Neue Belege der Wirksamkeit.' Therapiewoche 41: Gruenwald, J. (1991). 'Ginkgo biloba auf dem wissenschaftlischen Prüfstand.' Therapeutikon 5: Gruenwald, J. (1991). 'Hirnleistungsstörungen mit Ginkgo-biloba-Spezialextrakt therapierbar.' Cerebro 2: Gruenwald, J. (1991). 'Knoblauch - Mythos oder Medikament.' Pharmazeutische Rundschau 5: Schulz, V., W. Hübner, et al. (1991). 'Pflanzliche Lipidsenker.' Der Allgemeinarzt 8: Gruenwald, J. (1991). 'Knoblauch - Maturarznei gegen Arteriosklerose und zu hohe Blutfettwerter.' Österreichische Apotheker Zeitung: Gruenwald, J. (1991). 'Zu Pharmakologie des Knoblauchs.' Deutsche Apotheker Zeitung 27(suppl 24): Dieterle, A., G. Finke, et al. (1991). 'Ergebnisse zur Therapie mit Knoblauch.' Medizinische Welt 7a: Gruenwald, J. (1991). 'Arteriosklerose-Prophylaxe mit Knoblauch.' Pharmazeutische Rundschau 9: Gruenwald, J. (1991). 'Arteriosklerose-Prophylaxe mit Knoblauch.' PTA in der Apotheke 20: Gruenwald, J. (1991). Lipid-lowering therapy with garlic tablets. Comparison with other lipid-lowering drugs. Abhandlungen der Rheinisch-Westfälischen Akademie der Wissenschaften, Westdeutscher Verlag, Opladen. 87: Bloom, R., W. Hauss, et al. (1990). Wanderverhalten von Leukozyten in der Co-Kultur mit Endothelzellen. Arteriosklerose: Neue Aspekte aus Zellbiologie, Molekulargenetik, Epidemiologie und Klinik. G. Assmann, E. Betz, H. Heinle and H. Schulte, Vieweg-Verlag, Braunschwieg: Gruenwald, J. (1990). 'Knoblauch und Arteriosklerose.' Schweiz Z Ganzheitsmed 1(suppl. I): Luley, C., H. Wieland, et al. (1990). 'Bioavailability of Omega-3-Fatty Acids: Ethylester Preparations are as suitable as Triglyceride Preparations.' Akt. Ernähr. 713: Gruenwald, J., D. Laudahn, et al. (1990). 'Lipidsenkende Therapie. Unter besondere Berücksichtigung der Naturheilmittel.' Der Allgemeinarzt 12: Luley, C., H. Wieland, et al. (1990). Bioverfügbarkait zweier Präparationen von Omega-3-Fettsäuren. Omega-3-Fettsäuren. J. Wechsler and W. Swobodnik, VCH Verlagsges., Weinheim: Gruenwald, J. (1990). 'So verändert der Blutdruck Ihre Arterien.' Blutdruck Aktuell 4: Gruenwald, J. (1989). Testsysteme für antiatherogene Substanzen. Sekundärprevention der Arteriosklerose. H. Hoffmeister and E. Betz, Attempo Verlag, Tübingen: Gruenwald, J. and W. Völker (1989). 'Advanced morphological techniques in atherosclerosis research.' Advances in Histochemistry, submitted Gruenwald, J. (1989). The unspecific mesenchymal reaction. Modern Aspects of the Pathogenesis of Artherosclerosis. W. Hauss and R. Wissler, Westdeutscher Verlag, Opladen Gruenwald, J., G. Chaldakov, et al. (1989). The effect of calcium antagonists in experimental artherosclerosis, the underlaying cause for heart and cerebral vascular diseases. Cerebral Ischemia and Calcium. A. Hartmann and W. Kuschinsky, Springer Verlag, Heidelberg: Wülfroth, P.,Gruenwald, J., (1989), Differential effect of nicotinic acid derivatives on smooth muscle and endothelial cell proliferation, Basic Research in Cardiology, May/June 1989, Volume 84, Issue 3: Glukhova, M., M. Frid, et al. (1989). 'Expression of EDI fibronectin sequence in vascular smooth muscle cells is phenotype dependent.' J Cell Biol 109: Gruenwald, J., R. Bloom, et al. (1989). 'Migration von Monozyten und Granulozyten in Co-Kultur mit Endothelzellen.' Zeitschrift für Kardiologie(Supp. 6): Gruenwald, J. (1989). 'Knoblauchpräparate - Klinische Wirksamkeitsnachweise und Standardisierung.' Dtsch Apotheker Z 20: 1062a Gruenwald, J. (1989). 'Knoblauch und Arteriosklerose.' Deutsche Apotheker Zeitung 28(suppl 15): Gruenwald, J. (1989). 'Beneficial effect of risk factors for atherosclerosis.' Cardiology in Practice 10(supp 1): Gruenwald, J., R. Bloom, et al. (1989). The unspecific mesenchymal reaction. Modern Aspects of the pathogenesis of arteriosclerosis. W. Hauss, R. Wissler and H. Bauch, Wetsdeutscher Verlag, Opladen: Gruenwald, J. (1988). 'Hemmung der Migration und Proliferation glatter Gefäßwandzellen mit Flunarizin.' MMW 130(B52): Gruenwald, J., R. Bloom, et al. (1988). 'Visualization of macrophage motility through a confluent endothelial cell layer using time lapse video microscopy.' Eur J Cell Biol 22: Fredrich, M., P. Wülfroth, et al. (1988). 'Smooth muscle cell modulation in vitro is altered by deendothelialization in vivo.' Eur J Cell Biol 22: Gruenwald, J. (1988). 'Zeitraffer-Analysen zur Einschränkung von Tierversuchen in Pathologie und CV Dez2014.docx 14 / 17

15 Pharmacology.' LaborMedizin 3: Lankes, W., J. Gruenwald, et al. (1988). 'A Heparin binding protein involved in the inhibition of smooth muscle cell proliferation.' Biochemical Journal 251: Hämmerle, H., J. Fingerle, et al. (1988). 'Expression of smooth muscle myosin in relation to growth kinetics of cultured aortic smooth muscle cells.' Exp Cell Res 178: Gruenwald, J. and P. Wülfroth (1988). Aktivierende und inaktivierende Faktoren bei der Proliferation und Migration glatter Muskelzellen. Wachstumsfaktoren und Onkogenprodukte bei Entstehung und Regression der Arteriosklerose. D. Schettler and D. Marme, Springer Verlag, Berlin: Gruenwald, J. (1988). 'Arteriosklerose-Vorbeugung: in der Jugend beginnen?' Pharmazeutische Rundschau 9: Gruenwald, J., J. Fingerle, et al. (1987). 'Cytocontractile structures and proteins of smooth muscle cells during the formation of experimental lesions.' Exp Mol Path 46: Chaldakov, G. and J. Gruenwald (1987). 'Effect of colchicine on the ultrastructures of secretory-state smooth muscle cells from the rabbit artery wall.' Exp Path 31: Gruenwald, J. (1987). Activation of arterial wall cells, a general response to arteriosclerotic risk factors. Recent advances in arteriosclerosis research. W. Hauss and R. Wissler, Westdeutscher Verlag, Opladen: Gruenwald, J. and P. Wülfroth (1987). 'Effect of the three nicotinic acid derivatives Etofibrate. L 44 and L 44-0 on smooth muscle cell migration and proliferation.' Atheroma 7: Bauch, H., J. Gruenwald, et al. (1987). 'The Possible role of catecholamines in the pathogenesis of arteriosclerosis.' Exp Path 31: Gruenwald, J. (1987). 'Effects of anti-atherosclerotic substances on smooth muscle cell migration and proliferation analyzed by time-lapse video microscopy.' Int Angiol 6: Hauss, W., R. Wissler, et al. (1987). 'Recent advances in arteriosclerosis research.' 255. Gruenwald, J., A. Chobanian, et al. (1987). 'Smooth muscle cell migration and proliferation: atherogenic mechanisms in hypertension.' Atheroschlerosis 67: Bauch, H., P. Vischer, et al. (1987). 'Atherosclerosis risk factors and their influence on prostaglandin metabolism in cultured endothelial and smooth muscle cells.' Prostaglandins Clinic Res.: Gruenwald, J. (1987). 'Time lapse video microscopy of cultured cells and its use in cytopathology and pharmacology.' BioTechniques 5: Gruenwald, J. (1987). Histochemische, licht-, elektronen- und videomikroskopische Untersuchungstechniken in der Arterioskleroseforschung. Frühveränderungen bei der Atherogenese. E. Betz, Zuckschwerdt Verlag, München: Vankova, M. and J. Gruenwald (1987). 'Effect of serotonin and 5-hydroxyindole-3-acetic acid on smooth muscle cell proliferation.' Med Sci Res 15: Gruenwald, J., U. Bongartz, et al. (1987). 'Motility of smooth muscle cells, endithelial cells and macrophages analyzed by time-lapse video microscopy.' J Cell Biol 105: 128 a Gruenwald, J., U. Bongartz, et al. (1987). 'Migration of smooth muscle cell, endothelial cells and macrophages in separate and co-culture systems analyzed by time-lapse video microscopy.' Anticancer Res 7: Gruenwald, J. (1987). Migration und Proliferation glatter Muskelzellen unter dem Einfluß von Arteriosklerose-Risikofaktoren. Zell- und Gewebskulturmodelle in der Pathobiochemie der Bindegewebserkrankungen. N. Dettmar and I. Lindler, PCS-Verlag, Basel: Gruenwald, J. (1987). Einfluß von Arteriosklerose-Risikofaktoren auf Funktion und Morphologie kultivierter Gefäßwandzellen. Die Permeabilität der Gefäßwand. H. Hoffmeister and E. Betz, Wissenschaftliche Verlagsgesellscgaft, Stuttgart: Zidek, W., U. Heckmann, et al. (1987). 'Arterial resistance vessels in primary hypertension-evidence for altered cellular Ca 2+ metabolism.' J Cardiovasc Pharmacol 10: Gruenwald, J. (1986). 'Migration und Proliferation glatter Muskelzellen.' Funktionsanalyse biologischer Systeme 17: Gruenwald, J. (1986). 'Endothelial and smooth muscle cell culture model in pharmacology.' Eur J Cell Biol 42: Gruenwald, J. and U. Bongartz (1986). 'Time lapse video microscopy of smooth muscle cell proliferation, motility and morphology in hypertension and culture aging.' J Cell Biol 103: 424 a Lankes, W., B. Wolf, et al. (1986). 'Isolation and partial characterization of a cell surface receptor for basement membrane proteoheparan sulfate.' Frez Z Anal Chem 324: Gruenwald, J., A. Hesz, et al. (1985). 'Proliferation, morphology and LDL metabolism of the arterial endothelial cells cultured from normal and diabetic minipigs.' Exp Mol Path 42: Gruenwald, J. and W. Wischer (1985). 'Ultrastructural morphometry of cultivated smooth muscle cells CV Dez2014.docx 15 / 17

16 from normotensive and hypertensive rats.' Exp Path 27: Gruenwald, J. and W. Hauss (1985). 'Medikamentöse Regression zellulärer Veränderungen der Arteriosklerose in kombinierten Tier- und Zellkulturmodellen.' Klin Wochenschrift 63: Haudenschild, C. and J. Gruenwald (1985). 'Proliferative heteorogeneity of vascular smooth muscle cells and its alteration by injury.' Exp Cell Res 157: Hauss, W. and J. Gruenwald (1985). 'Einiges zur Geschichte und zu aktuellen Problemen der Atherogeneseforschung.' Med Welt 36: Gruenwald, J., H. Bauch, et al. (1985). 'Smooth muscle cell cultures from hypertensive rats exhibit an increased reactivity to catecholamines.' J Cell Biol 5: 111 a Hämmerle, H., J. Gruenwald, et al. (1985). 'Cytocontractile proteins and structures of medial and intimal smooth muscle cells in situ.' Blickpunkt Innere Med 7: Haudenschild, C., J. Gruenwald, et al. (1985). 'Effects of DOC/salt hypertension on migration and proliferation of smooth muscle cells in culture.' Hypertension 7(suppl I): Bauch, H., J. Gruenwald, et al. (1985). 'A possible role of catecholamines in atherogenesis and subsequent complications of atherosclerosis.' Blickpunkt Innere Med 7: Gruenwald, J. (1985). 'Activation of arterial wall cells, a general response to arteriosclerotic risk factors.' Blickpunkt Innere Med 7: Gruenwald, J. and C. Haudenschild (1985). 'The influence of antiplatelet drugs on balloon injury stimulated migration in cultured smooth muscle cells.' Artery 12: Gruenwald, J. and U. Bongartz (1985). 'Time lapse video microscopy of smooth muscle cell proliferation and motility in aging.' Eur J Cell Biol 39: Hauss, W., J. Mey, et al. (1984). Effect des substances inhibitrices du mésenchyme sur la proliferation des cellules mésenchymateuses. Pharmacologie cellulaire et moléculaire des maladies du tissu conjonctif. L. Robert and G. Greiling, Alinea, Reims Buddecke, E., J. Gruenwald, et al. (1984). Energie- und Proteoglykanstoffwechsel proliferiender Gefäßwandzellen. Gefäßwandelemente in vivo und in vitro. H. Fischer and E. Betz, Wissenschaftliche Verlaggesellschaft, Stuttgart: Gruenwald, J. and J. Mey (1984). 'Effect of renal and genetic hypertension and staphylolysine on smooth muscle cells derived from different regions of the aorta.' Pathologie-Biologie 32: Gruenwald, J. and C. Haudenschild (1984). 'Intimal injury in vivo activates vascular smooth muscle cell migration and explant outgrowth in vitro.' Arteriosclerosis 3: Gruenwald, J. and C. Haudenschild (1984). 'Time lapse video analysis of interdivision times and motility of cultured smooth muscle cells after in vivo balloon injury.' Proceedings of the 5th Annual European Conference on Vascular Biology: Gruenwald, J., E. Meyer-Grothues, et al. (1984). 'About the effect of risk factors on the structure and the proliferation of arterial wall cells. I. Changes in structure and proliferation of cultured aortic smooth muscle cells from hypertensive-diabetic rats.' Exp Path 25: Mey, J., J. Gruenwald, et al. (1984). 'About the effect of risk factors on the structure and the proliferation of arterial wall cells. II. Changes in the structure and proliferation of cultivated aortic endothelial cells from hypertensive minipigs.' Exp Path 25: Gruenwald, J. and C. Haudenschild (1983). 'Vascular smooth muscle cell modulation in vivo and growth potential in vitro.' In Vitro 19: Gruenwald, J. and C. Haudenschild (1983). 'Effects of in vivo hypophysectomy and antiplatelet drugs on rat smooth muscle cell migration and proliferation in vitro.' Arteriosclerosis 3: 468 a Gruenwald, J., J. Mey, et al. (1983). 'Cultivated human arterial smooth muscle cells. The effect of donor age, blood pressure, diabetes, and smoking on in vitro cell growth.' Pathologie-Biologie 31( ) Gruenwald, J. and C. Haudenschild (1983). 'Heterogeneity of interdivision times of primary vascular smooth muscle cell cultures.' J Cell Biol 97: 396 a Mey, J., J. Gruenwald, et al. (1983). Antirheumatic drugs and their influence on the arterial wall cells of normal and of injured animals. Clinical implications of recent research results in arteriosclerosis. W. Hauss and R. Wissler, Westdeutscher Verlag, Opladen: Robenek, H., I. Rassat, et al. (1982). 'Studies on the labeling and topography of low density lipoprotein receptors on the surface of cultured human skin fibroblasts using colloidal gold in conjunction with surface replication techniques.' Eur J Cell Biol 27: Gruenwald, J., H. Robenek, et al. (1982). 'In vivo and in vitro cellular changes in experimental hypertension.' Exp Mol Path 36: Kirchhof, B. and J. Gruenwald (1982). 'Thrombin inhibition and thrombin generation by cultured smooth muscle cell subtypes of hypertensive and diabetic rats.' Thrombosis and Haemostasis 48: Gruenwald, J. and C. Haudenschild (1982). 'Vascular smooth muscle cell activation and outgrowth.' J CV Dez2014.docx 16 / 17

17 Cell Biol 95: 330 a Gruenwald, J. and C. Haudenschild (1982). 'Proliferation and motility of cultured smooth muscle cells from diabetic rats.' Arteriosclerosis 2: 414 a Gruenwald, J., W. Schäper, et al. (1982). 'Special characteristics of cultured smooth muscle cells subtypes of hypertensive and diabetic rats.' Artery 11: Schmidt, A., J. Gruenwald, et al. (1982). '( 35 S) proteoglycan metabolism of arterial smooth muscle cells cultured from normotensive and hypertensive rats.' Atherosclerosis 45: Robenek, H., A. Hesz, et al. (1982). 'A correlative study on the topographical distribution of the receptors for low density lipoprotein (LDL) conjugated to colloidal gold in cultured human skin fibroblasts employing thin section, freeze frature, deep-etching and surface replication techniques.' Eur J Cell Biol 27: Robenek, H., A. Hesz, et al. (1982). 'Low density lipoprotein-gold conjugates employed in conjugation with surface replication techniques as a method for determing distribution of LDL-receptors on the cell surface of fibroblasts.' Electron Microscopy 3: Zidek, W., H. Lsse, et al. (1982). 'Intracellular Na + and Ca 2+ activities in aortic smooth muscle cells from spontaneously hypertensive rats.' Exp Med 181: Gruenwald, J., J. Mey, et al. (1981). 'Hypertension induced in vivo ans in vitro cellular changes. Electronmicroscopic and morphometric studies of aoertic endothelial and smooth muscle cells.' Beitr Elektronenmikroskop Direktabb Oberfl 14: Mey, J., J. Gruenwald, et al. (1981). Der Einfluß der Azetylsalizylsäure auf Proliferation und Morphe der durch sklerogene Faktoren stimulierten Aortenwandzellen. Thrombose und Atherrogenese. K. Breddin, Verlag Gerhard Witzstock, Baden-Baden, New York Hauss, W., J. Mey, et al. (1981). Modernes Konzept über den Mechanismus der Pathogenese der Arterieosklerose. Thrombose und Atherogenese. K. Breddin. Verlag Gerhard Witzstock, Baden-Baden, New York Gruenwald, J., J. Mey, et al. (1980). 'Growth rate difference between ASMC cultivated from rats impaired by short- or longterm hypertension.' Artery 8: Gruenwald, J., J. Mey, et al. (1980). 'Differences between aortic SMC from normo- and hypertensive rats and minipigs.' Eur J Cell Biol 22: Gruenwald, J., (1978), Untersuchungen über die Zerstörung des Periderms der Himbeerrute durch die Larven der Himbeerrutengallmücke Thomasiniana theobaldi und den Pilz, Promotion Universität Heidelberg CV Dez2014.docx 17 / 17

The Mrs.Sporty Story Founders and History

Welcome to The Mrs.Sporty Story Founders and History 2003: vision of Mrs. Sporty is formulated 2004: pilot club opened in Berlin 2005: launch of Mrs.Sporty franchise concept with Stefanie Graf Stefanie

Mehr

How does the Institute for quality and efficiency in health care work?

Health Care for all Creating Effective and Dynamic Structures How does the Institute for quality and efficiency in health care work? Peter T. Sawicki; Institute for Quality and Efficiency in Health Care.

Mehr

Introduction to the diploma and master seminar in FSS 2010. Prof. Dr. Armin Heinzl. Sven Scheibmayr

Contemporary Aspects in Information Systems Introduction to the diploma and master seminar in FSS 2010 Chair of Business Administration and Information Systems Prof. Dr. Armin Heinzl Sven Scheibmayr Objective

Mehr

Space policy implementation. Example of Austria. Dr. Thomas Geist FFG Austrian Research Promotion Agency

ALR-PPT-0061-2016_rev0 Space policy implementation Example of Austria Dr. Thomas Geist FFG Austrian Research Promotion Agency Horizon 2020 Space Information Day Ljubljana, 20 April 2016 0 AUSTRIA IN GLOBAL

Mehr

JAHRESERGEBNISSE 2016 INVESTORENANWERBUNG

JAHRESERGEBNISSE 016 INVESTORENANWERBUNG BERLIN, 09.0.01 Achim Hartig Managing Director Investor Consulting www.gtai.com Executive Summary 016 sind 01 Vorhaben, die.6 geplanten Arbeitsplätze beinhalten,

Mehr

Vocational Education and Training (VET) in Switzerland and Schaffhausen

Presentation at Information Event February 18, 2015 Karin Baumer, Office for Vocational Education and Training Vocational Education and Training (VET) in Switzerland and Schaffhausen Seite 1 Commercial

Heilen Mit Vitalstoffen Pdf File Free

Mehr

TMF projects on IT infrastructure for clinical research

Welcome! TMF projects on IT infrastructure for clinical research R. Speer Telematikplattform für Medizinische Forschungsnetze (TMF) e.v. Berlin Telematikplattform für Medizinische Forschungsnetze (TMF)

Mehr

INTERREG IIIa Project R&D - Ready for Research and Development Project results and ongoing activities

INTERREG IIIa Project R&D - Ready for Research and Development Project results and ongoing activities Györ, 5th December 2007 Key regions + perifary for surveys Background objectives CENTROPE needs a strategy

Mehr

Geistes-, Natur-, Sozial- und Technikwissenschaften gemeinsam unter einem Dach. Programmes for refugees at Bielefeld University

Programmes for refugees at Bielefeld University 1 Bielefeld University Funded in 1969 Middle-sized university with 28.000 students, 1800 of them international students, 13 faculties: main focus on Natural

Mehr

AVL The Thrill of Solutions. Paul Blijham, Wien, 04.07.2005

AVL The Thrill of Solutions Paul Blijham, Wien, 04.07.2005 The Automotive Market and its Importance 58 million vehicles are produced each year worldwide 700 million vehicles are registered on the road

Mehr

There are 10 weeks this summer vacation the weeks beginning: June 23, June 30, July 7, July 14, July 21, Jul 28, Aug 4, Aug 11, Aug 18, Aug 25

Name: AP Deutsch Sommerpaket 2014 The AP German exam is designed to test your language proficiency your ability to use the German language to speak, listen, read and write. All the grammar concepts and

Mehr

Call Centers and Low Wage Employment in International Comparison

Wissenschaftszentrum Nordrhein-Westfalen Kulturwissenschaftliches Institut Wuppertal Institut für Klima, Umwelt, Energie Institut Arbeit und Technik Call Centers and Low Wage Employment in International

Mehr

European Qualification Strategies in Information and Communications Technology (ICT)

European Qualification Strategies in Information and Communications Technology (ICT) Towards a European (reference) ICT Skills and Qualification Framework Results and Recommendations from the Leornardo-da-Vinci-II

Mehr

Gesundheitssystem Österreich FINANZIERUNG

Gesundheitssystem Österreich FINANZIERUNG Ausgaben Entwicklung der Gesundheitsausgaben in Österreich in % des Bruttosozialproduktes 10 8 6 4 2 0 1971 1973 1975 1977 1979 1981 1982 1983 1984 1985 1986 1987

Mehr

Cluster Health Care Economy has been established in 2008 Regional approach to develop health care industries Head of the cluster is Ms.

How to develop health regions as driving forces for quality of life, growth and innovation? The experience of North Rhine-Westphalia Dr. rer. soc. Karin Scharfenorth WHO Collaborating Centre for Regional

Mehr

The Swiss paediatric Surveillance unit SPSU contributes to change in Public Health Policy and practice at an international level

The Swiss paediatric Surveillance unit SPSU contributes to change in Public Health Policy and practice at an international level Mäusezahl M, Rudin C, Beeli D SPSU Research network formed by 33 paediatric

Mehr

Simulation of Cold Forging. - examples of applications from around the world - Dr. Gerhard H. Arfmann CPM GmbH, Herzogenrath

Simulation of Cold Forging - examples of applications from around the world - Dr. Gerhard H. Arfmann CPM GmbH, Herzogenrath 1 CV Dr. Arfmann Till 1974 High School at Kreisgymnasium Halle, Halle Westfalen,

Mehr

DR. KALLIWODA CAPITAL MARKETS CONFERENCES

Tel.: +49 69 972 058 53 Mobil: +49 172 61 90 796 Email: nk@kalliwoda.com Web: DR. KALLIWODA CAPITAL MARKETS CONFERENCES Since 2003, we are an independent research firm, performing additionally national

Mehr

Environmental management in German institutions of higher education: Lessons learnt and steps toward sustainable management

Environmental management in German institutions of higher education: Lessons learnt and steps toward sustainable management Lüneburg, Juni 23/24, 2005 Joachim Müller Sustainable Management of Higher Education

Heilen mit vitalstoffen pdf files Mehr

Munich Center for Technology in Society

COST Action TU1002 Accessibility Instruments for Planning Practice in Europe Munich Center for Technology in Society Klaus Mainzer Founding Director Lehrstuhl für Philosophie und Wissenschaftstheorie Complex

Mehr

From a Qualification Project to the Foundation of a Logistics Network Thuringia. Logistik Netzwerk Thüringen e.v.

From a Qualification Project to the Foundation of a Logistics Network Thuringia Strengthening the role of Logistics through Corporate Competence Development a pilot project by Bildungswerk der Thüringer

Mehr

Open Access and Academic Spring?

Open Access and Academic Spring? Terje Tüür-Fröhlich terje.tuur@jku.at 6. LINZER MEDIENKOMPETENZ-SYMPOSION 19.- 20. 4. 2013 Social Media und neue soziale Bewegungen Chancen, Potentiale, Risiken Johannes

Mehr

Demografic Agency for the economy in Lower Saxony. Johannes Grabbe s presentation at the German-British trades union forum in London, 2nd July 2012

Demografic Agency for the economy in Lower Saxony Johannes Grabbe s presentation at the German-British trades union forum in London, 2nd July 2012 Collaborative project of: Governmental aid: Content 1.

Mehr

Mobility trends in the Baltic Sea Region

Mobility trends in the Baltic Sea Region Conference on promoting strategic and innovative mobility for students and researchers 23 November 2010 in Copenhagen by Dr. Birger Hendriks Outline Forms of mobility

Mehr

Possible Solutions for Development of Multilevel Pension System in the Republic of Azerbaijan

Possible Solutions for Development of Multilevel Pension System in the Republic of Azerbaijan by Prof. Dr. Heinz-Dietrich Steinmeyer Introduction Multi-level pension systems Different approaches Different

Mehr

Die Bedeutung neurowissenschaftlicher Erkenntnisse für die Werbung (German Edition)

Die Bedeutung neurowissenschaftlicher Erkenntnisse für die Werbung (German Edition) Lisa Johann Click here if your download doesn't start automatically Download and Read Free Online Die Bedeutung neurowissenschaftlicher

Mehr

Consultant Profile Anja Beenen (née Weidemann) Experience

Consultant Profile Anja Beenen (née Weidemann) Profil M Beratung für Human Resources Management GmbH & Co. KG Berliner Straße 131 42929 Wermelskirchen Telephone: (+49) 21 96 / 70 68 204 Telefax: (+49)

Mehr

Social Sciences and Humanities role in Social Innovation Some key observations from the experience of TU Dortmund University sfs

Social Sciences and Humanities role in Social Innovation Some key observations from the experience of TU Dortmund University sfs Jürgen Howaldt & Dmitri Domanski Rethinking the role of Social Sciences

Mehr

DEUTSCHE NORM September 2000

DEUTSCHE NORM September 2000 Corrosion protection of metals Electrodeposited coatings of zinc with supplementary treatment on iron and steel English version of DIN EN 12329 { EN 12329 ICS 25.220.40 Korrosionsschutz

Mehr

Themen für Seminararbeiten WS 15/16

Themen für Seminararbeiten WS 15/16 Institut für nachhaltige Unternehmensführung Themenblock A: 1) Carsharing worldwide - An international Comparison 2) The influence of Carsharing towards other mobility

Mehr

Unternehmensweite IT Architekturen

Unternehmensweite IT Architekturen Part 1: IT Systems Architecture, Roles and Responsibilities of IT Architects Part 2: Solution Architecture, based on a practical Case Study Part 3: SOA (Service Oriented

Mehr

Energieeffizienz und Erneuerbare Energien Programme der EZ -- ein Zwischenstand

Energieeffizienz und Erneuerbare Energien Programme der EZ -- ein Zwischenstand Climate Policy Capacity Building Seminar Kiew 07.10.04 Klaus Gihr Senior Project Manager Europe Department Was sind unsere

Mehr

Konferenz SIGNO-Strategieförderung

Konferenz SIGNO-Strategieförderung BMWi / PtJ am 19.03.10 Dr. Frank-Roman Lauter Leiter der Geschäftsentwicklung des Berlin-Brandenburg Centrums für Regenerative Therapien Charite Summit 17.03.10 Translationszentrum

Mehr

Contractual Management Institute CMI Berlin. The institute for law and sustainable networking

1 Contractual Management Institute CMI Berlin The institute for law and sustainable networking Fields of Activities 1 Contractual Networking 1.1 Contractual Management Schuhmann, R., and Eichhorn, B. (2017),

Mehr

Essential Healthcare in Africa

Deutsch-Afrikanisches Wirtschaftsforum NRW 23. Februar 2016 Dortmund Essential Healthcare in Africa Roland Göhde Senior Managing Director Sysmex Partec GmbH Member of: INTRODUCTION ON SYSMEX PARTEC IN

Mehr

Intensive PLUS. Intensive PLUS

Prices & Dates 2018 Notes: à more of our course options, accommodations and services you can find below: www.learn-german.com à please write to k.schimmeyer@learn-german.com, if you wish to have extended

Mehr

DEMAT GmbH Company Profile

DEMAT GmbH Company Profile DEMAT GmbH Company Profile - one of the most renowned trade fair organisers in Germany - since 1994 organiser of the World Fair EuroMold in Frankfurt / Main - constantly developing

Mehr

DENTAL IMPLANTS BY CAMLOG medical

IMPLANT PASS DENTAL IMPLANTS BY CAMLOG medical devices made in germany for your well-being and a natural appearance. Personal data Surname First name Address ZIP code City Date of birth Health insurance

Mehr

Corporate Digital Learning, How to Get It Right. Learning Café

0 Corporate Digital Learning, How to Get It Right Learning Café Online Educa Berlin, 3 December 2015 Key Questions 1 1. 1. What is the unique proposition of digital learning? 2. 2. What is the right digital

Mehr

Katharina Burkardt Head of Communications Department Press Spokesperson

Housing Germany Katharina Burkardt Head of Communications Department Press Spokesperson Federal Union of German Housing and Real Estate Enterprises GdW and its member companies GdW is the biggest head

Mehr

ERASMUS-INTENSIVE-PROGRAMME B E A M

ERASMUS-INTENSIVE-PROGRAMME B E A M Building European Identity through Spirit, Sense and Meaning for 1 st Project-Meeting (26. 4. 2009 10. 5. 2009) HISTORY 2006 / 2007 Change of Teacher-Training - Institution

Mehr

Dun & Bradstreet Compact Report

Dun & Bradstreet Compact Report Identification & Summary (C) 20XX D&B COPYRIGHT 20XX DUN & BRADSTREET INC. - PROVIDED UNDER CONTRACT FOR THE EXCLUSIVE USE OF SUBSCRIBER 86XXXXXX1. ATTN: Example LTD Identification

Mehr

EXPERT SURVEY OF THE NEWS MEDIA

EXPERT SURVEY OF THE NEWS MEDIA THE SHORENSTEIN CENTER ON THE PRESS, POLITICS & PUBLIC POLICY JOHN F. KENNEDY SCHOOL OF GOVERNMENT, HARVARD UNIVERSITY, CAMBRIDGE, MA 0238 PIPPA_NORRIS@HARVARD.EDU. FAX:

Mehr

ECDN General Assembly Brussels 11th December 2014 German Society for Home Economics Activities related to reference budgets

Fachausschuss Beratung für Haushalt und Verbrauch Deutsche Gesellschaft für Hauswirtschaft e.v. (dgh) ECDN General Assembly Brussels 11th December 2014 German Society for Home Economics Activities related

Mehr

Hamburg is Germany s Gateway to the World. Germany s preeminent centre of foreign trade and major hub for trade with the Baltic Sea region

in million Euro International trading metropolis Hamburg is Germany s Gateway to the World. Germany s preeminent centre of foreign trade and major hub for trade with the Baltic Sea region 8. Foreign trade

Mehr

Lessons learned VC Investment Erfahrungen

Lessons learned VC Investment Erfahrungen Venture Capital Club München, 24.10.2007 Bernd Seibel General Partner Agenda Key TVM Capital information Investorenkreis Gesellschafterkreis Investment Konditionen

Mehr

Yale Humboldt Consumer Law Lectures

Monday, June 6, 2016, 2 7 p.m. Humboldt University Berlin, Senatssaal Yale Humboldt Consumer Law Lectures Prof. Richard Brooks Professor of Law, Columbia Law School Prof. Henry B. Hansmann Professor of

Mehr

Providers of climate services in Germany

Providers of climate services in Germany National Dialog Prof. Dr. Maria Manez Costa Dr. Jörg Cortekar 2 Procedure Mapping of climate services providers - Germany Network development between the providers

Mehr

Der Schweizer Hotelmarkt im Vergleich

Der Schweizer Hotelmarkt im Vergleich Dennis Spitra Business Development Manager Swiss Hospitality Investment Forum Preview, Bern 27. November 2014 STR Global STR Global verfolgt Angebots- und Nachfragedaten

Mehr

DR. KALLIWODA CAPITAL MARKETS CONFERENCES

Tel.: +49 69 972 058 53 Mobil: +49 172 61 90 796 Email: nk@kalliwoda.com Web: DR. KALLIWODA CAPITAL MARKETS CONFERENCES Since 2003, we are an independent research firm, performing additionally national

Mehr

Produktentwicklung bei MAM

Produktentwicklung bei MAM Umsetzung der Projektekette in PM-Smart The MAM Success Story: Intelligent design for baby products Like all big success stories, MAM started with a visionary idea: In 1976 the

Mehr

Integrated public support services for an urban economy: the Vienna Business Agency's approach

Integrated public support services for an urban economy: the Vienna Business Agency's approach Alfried Braumann Vienna Business Agency, Economic Policy and EU-Affairs Vienna, January 27, 2015 Folie 2 Vienna

Mehr

Rolle und Aktivitäten der ICRP und von UNSCEAR

Rolle und Aktivitäten der ICRP und von UNSCEAR Wolfgang Weiss, Oberschleißheim oder wie eine UN-Organisation die deutsche Gesetzgebung beeinflusst UNSCEAR: United Nation Scientific Committee on the Effects

Mehr

An Introduction to Monetary Theory. Rudolf Peto

An Introduction to Monetary Theory Rudolf Peto 0 Copyright 2013 by Prof. Rudolf Peto, Bielefeld (Germany), www.peto-online.net 1 2 Preface This book is mainly a translation of the theoretical part of my

Mehr

IATUL SIG-LOQUM Group

Purdue University Purdue e-pubs Proceedings of the IATUL Conferences 2011 IATUL Proceedings IATUL SIG-LOQUM Group Reiner Kallenborn IATUL SIG-LOQUM Group Reiner Kallenborn, 'IATUL SIG-LOQUM Group.' Proceedings

Mehr

Online Learning in Management

43 rd EUCEN Conference 2012 Workshop: Supporting the individual learner in ULLL The Makes and Brakes of Collaborative E-Learning: Online Learning in Management - A case study - Dr. Marion Bruhn-Suhr University

Mehr

Aktuelle europäische Entwicklungen HMPC

Aktuelle europäische Entwicklungen HMPC Dr. Jacqueline Wiesner J. Wiesner BfArM im Dialog 26.04.2016 Seite 1 Inhaltsverzeichnis 1. 2004-2014 2. Entwicklungen 2015-2016 3. What s coming up? J. Wiesner BfArM

Mehr

GfK INSIGHT SUMMIT Herzlich Willkommen! Be Connected: Mit innovativen Ansätzen den vernetzten Konsumenten erreichen.

GfK INSIGHT SUMMIT 2017 Be Connected: Mit innovativen Ansätzen den vernetzten Konsumenten erreichen. Herzlich Willkommen! 1 To objectively assess the Connected Consumer, GfK has developed an index taking

Mehr

Big Data Analytics. Fifth Munich Data Protection Day, March 23, Dr. Stefan Krätschmer, Data Privacy Officer, Europe, IBM

Big Data Analytics Fifth Munich Data Protection Day, March 23, 2017 C Dr. Stefan Krätschmer, Data Privacy Officer, Europe, IBM Big Data Use Cases Customer focused - Targeted advertising / banners - Analysis

Mehr

Scenario Building Workshop - Interplay of problem framings

Transdiciplinary Conference Inter- and Transdisciplinary Problem Framing, ETH Zürich, 27-28 November 2008 Scenario Building Workshop - Interplay of problem framings PD Dr. Rolf Meyer*, Dr. Martin Knapp*,

Mehr

Quality Management is Ongoing Social Innovation Hans-Werner Franz

Quality Management is Ongoing Social Innovation Hans-Werner Franz ICICI Conference, Prague 1-2 October 2009 What I am going to tell you social innovation the EFQM Excellence model the development of quality

Mehr

Which data and when?

PRO-data for market access in Germany where and when? Frank-Ulrich Fricke PRO-data for market access in Germany where and when? AMNOG the German assessment Which data and when? Requirements to be met Seite

Mehr

Wolfgang Karl Göhner

International Conference Energy Management in Cultural Heritage The Impact of EU Legislation on Cultural Heritage Observatory Function of the EHLF and Implementation in the Federal Republic of Germany

Mehr

The German professional Education System for the Timber Industry. The University of Applied Sciences between vocational School and University

Hochschule Rosenheim 1 P. Prof. H. Köster / Mai 2013 The German professional Education System for the Timber Industry The University of Applied Sciences between vocational School and University Prof. Heinrich

Mehr

Women Entrepreneurship in Germany and Access to Capital

Summary Slide Women Entrepreneurship in Germany and Access to Capital Women Entrepreneurship in Germany and Access to Capital Presentation at ESTRAD Lecture Exploring Growth Financing for Women Entrepreneurs,

Mehr

Agenda Introduction The Founding Ideas Walter Eucken and the Ordnungpolitik Alfred Müller-Armack and the Ethical Dimension of the Social Market Econom

Sixty Years of Social Market Economy: Orientation in Post-War Times, after Reunification, and during the Current Economic Crisis Berthold U. Wigger Karlsruhe Institute of Technology (KIT) Chair of Public

Mehr

Martin Luther. Click here if your download doesn't start automatically

Die schönsten Kirchenlieder von Luther (Vollständige Ausgabe): Gesammelte Gedichte: Ach Gott, vom Himmel sieh darein + Nun bitten wir den Heiligen Geist... der Unweisen Mund... (German Edition) Martin

Mehr

The Future Internet in Germany and Europe

The Future Internet in Germany and Europe David Kennedy Direktor Eurescom GmbH Heidelberg, Deutschland Starting point.. The innovative society and sustainable economy of Europe 2020 will be based on ICT

Mehr

Introduction Classified Ad Models Capital Markets Day Berlin, December 10, 2014. Dr Andreas Wiele, President Marketing and Classified Ad Models

Capital Markets Day Berlin, December 10, 2014 Dr Andreas Wiele, President Marketing and Classified Ad Models Axel Springer s transformation to digital along core areas of expertise 3 Zimmer mit Haus im

Mehr

Darstellung und Anwendung der Assessmentergebnisse

Process flow Remarks Role Documents, data, tool input, output Important: Involve as many PZU as possible PZO Start Use appropriate templates for the process documentation Define purpose and scope Define

Mehr

The world has changed: always on Marken erfordern neue, innovative Wege des Denken und Handeln um Konsumenten zu aktivieren und zu betreuen.

welcome.success TO EMPORER YOUR BRAND AND SERVICE VALUES Über uns WE BUILD GREAT VALUES Als 'full service marketing and brand communication'- Unternehmen verfügen wir über einen breiten Kompetenzpool,

Mehr

Max und Moritz: Eine Bubengeschichte in Sieben Streichen (German Edition)

Max und Moritz: Eine Bubengeschichte in Sieben Streichen (German Edition) Wilhelm Busch Click here if your download doesn't start automatically Max und Moritz: Eine Bubengeschichte in Sieben Streichen

Mehr

Presentation of BFI OÖ s Health and Social Care Training Programme in 2012

Presentation of BFI OÖ s Health and Social Care Programme in 2012 BFI OÖ Akademie für Gesundheits- und Sozialberufe 1 al Migrants Beginners Lateral entrants University Access Vocational Educated People

Mehr

Berlin Demography Forum, March 18-20, Demography Compass

Berlin Demography Forum, March 18-20, 2015 Demography Compass In addition to the panel discussions, the Berlin Demography Forum wants to contribute some original insights. It has developed a set of indicators

Mehr

Univ. Prof. Dr. Veronika Fialka-Moser

Univ. Prof. Dr. Veronika Fialka-Moser Vienna Hospital Association Allgemeines Krankenhaus - Universitätskliniken Vorstand der Univ.- Klinik für Physikalische Medizin und Rehabilitation Währinger Gürtel

Mehr

EVANGELISCHES GESANGBUCH: AUSGABE FUR DIE EVANGELISCH-LUTHERISCHE LANDESKIRCHE SACHSEN. BLAU (GERMAN EDITION) FROM EVANGELISCHE VERLAGSAN

EVANGELISCHES GESANGBUCH: AUSGABE FUR DIE EVANGELISCH-LUTHERISCHE LANDESKIRCHE SACHSEN. BLAU (GERMAN EDITION) FROM EVANGELISCHE VERLAGSAN DOWNLOAD EBOOK : EVANGELISCHES GESANGBUCH: AUSGABE FUR DIE EVANGELISCH-LUTHERISCHE

Mehr

Country fact sheet. Noise in Europe overview of policy-related data. Germany

Country fact sheet Noise in Europe 2015 overview of policy-related data Germany April 2016 The Environmental Noise Directive (END) requires EU Member States to assess exposure to noise from key transport

Mehr

Sustainability Balanced Scorecard as a Framework for Eco-Efficiency Analysis

Sustainability Balanced Scorecard as a Framework for Eco-Efficiency Analysis Andreas Möller amoeller@uni-lueneburg.de umweltinformatik.uni-lueneburg.de Stefan Schaltegger schaltegger@uni-lueneburgde www.uni-lueneburg.de/csm

Mehr

Virtuelle Mobilität für die Internationalisierung und innovative Hochschuldidaktik in der wissenschaftlichen Weiterbildung

Virtuelle Mobilität für die Internationalisierung und innovative Hochschuldidaktik in der wissenschaftlichen Weiterbildung International Day 2017, Hagen 28. September 2017 Dr. Daniel Otto ID 2017 INTERNATIONALISIERUNG

Mehr

University of Tirana

University of Tirana Address: Sheshi Nënë Tereza ; www.unitir.edu.al Tel: 04228402; Fax: 04223981 H.-D. Wenzel, Lehrstuhl Finanzwissenschaft, OFU Bamberg 1 University of Tirana The University of Tirana

Mehr

Handbuch der therapeutischen Seelsorge: Die Seelsorge-Praxis / Gesprächsführung in der Seelsorge (German Edition)

Handbuch der therapeutischen Seelsorge: Die Seelsorge-Praxis / Gesprächsführung in der Seelsorge (German Edition) Reinhold Ruthe Click here if your download doesn't start automatically Handbuch der therapeutischen

Mehr

Austria Regional Kick-off

Austria Regional Kick-off Andreas Dippelhofer Anwendungszentrum GmbH Oberpfaffenhofen (AZO) AZO Main Initiatives Andreas Dippelhofer 2 The Competition SPOT THE SPACE RELATION IN YOUR BUSINESS 3 Global

Mehr

2015 Annual General Assembly of Members on Friday, 18 September 2015, 17:00 to 20:00 hours at Coaching Institut Berlin, Waldstr.

Berlin and Seefeld, 20 August 2015 Dear EASC colleague, We warmly invite you to this year s of Members on Friday, 18 September 2015, 17:00 to 20:00 hours at Coaching Institut Berlin, Waldstr. 32, 10551

Mehr

Aktueller Stand der französischen Niederlassungen und Investitionen in Deutschland

Chris Schmidt - istockphoto Aktueller Stand der französischen Niederlassungen und Investitionen in Deutschland Lecongrès, 24. Oktober 2014 Dr. Benno Bunse Geschäftsführer Germany Trade and Invest Agenda

Mehr

WP2. Communication and Dissemination. Wirtschafts- und Wissenschaftsförderung im Freistaat Thüringen

WP2 Communication and Dissemination Europa Programm Center Im Freistaat Thüringen In Trägerschaft des TIAW e. V. 1 GOALS for WP2: Knowledge information about CHAMPIONS and its content Direct communication

Mehr

Customer-specific software for autonomous driving and driver assistance (ADAS)

This press release is approved for publication. Press Release Chemnitz, February 6 th, 2014 Customer-specific software for autonomous driving and driver assistance (ADAS) With the new product line Baselabs

Mehr

Lessons learned from co-operation The project Virtual interaction with Web 2.0 in companies

Lessons learned from co-operation The project Virtual interaction with Web 2.0 in companies 43 rd EUCEN Conference Lena Oswald Center of Continuing University Education Hamburg University Agenda The project

Mehr

Bringing sense and simplicity to life

Neue Einsatzbereiche der digitalen Spracherkennung: Informationsaufbereitung für Elektronische Patientenakten mit Wissensbanken und medizinischen Terminologien Klaus Stanglmayr Wednesday, June 20, 2007

Mehr

Exercise (Part II) Anastasia Mochalova, Lehrstuhl für ABWL und Wirtschaftsinformatik, Kath. Universität Eichstätt-Ingolstadt 1

Exercise (Part II) Notes: The exercise is based on Microsoft Dynamics CRM Online. For all screenshots: Copyright Microsoft Corporation. The sign ## is you personal number to be used in all exercises. All

Mehr

New Forms of Risk Communication Workshop 6: Arzneimitteltherapiesicherheit (AMTS) Dr. Norbert Paeschke, BfArM

New Forms of Risk Communication Workshop 6: Arzneimitteltherapiesicherheit (AMTS) Dr. Norbert Paeschke, BfArM Bundesinstitut für Arzneimittel und Medizinprodukte Das BfArM ist ein Bundesinstitut im Geschäftsbereich

Mehr

Support Technologies based on Bi-Modal Network Analysis. H. Ulrich Hoppe. Virtuelles Arbeiten und Lernen in projektartigen Netzwerken

Support Technologies based on Bi-Modal Network Analysis H. Agenda 1. Network analysis short introduction 2. Supporting the development of virtual organizations 3. Supporting the development of compentences

Mehr

Seismic Hazard Harmonisation in Europe (SHARE)

DGEB-Workshop, 27. May 2014 SHARE: Seismic Hazard Harmonisation in Europe DGEB-Publication No. 16 Seismic Hazard Harmonisation in Europe (SHARE) DGEB-Workshop in Frankfurt a.m., Germany 27. May 2014 C.

Mehr

Quality improvement (QI) and Quality Assurance (QA) in HIV prevention

Quality improvement (QI) and Quality Assurance (QA) in HIV prevention HIV Prevention Commission Communication on combating HIV in the EU and neighbouring countries, 2009-2013 Core Prevention Focus priority

Mehr

Exercise (Part XI) Anastasia Mochalova, Lehrstuhl für ABWL und Wirtschaftsinformatik, Kath. Universität Eichstätt-Ingolstadt 1

Exercise (Part XI) Notes: The exercise is based on Microsoft Dynamics CRM Online. For all screenshots: Copyright Microsoft Corporation. The sign ## is you personal number to be used in all exercises. All

Mehr

Making quality visible. National Quality Certificate for Old Age and Nursing Homes in Austria (NQC)

Making quality visible. National Quality Certificate for Old Age and Nursing Homes in Austria (NQC) Human Rights Council Genf, 15 September 2015 The Austrian System of Long Term Care System: 2 main components:

Mehr

HEALTH AT A GLANCE Wo steht Deutschland?

HEALTH AT A GLANCE 2015 Wo steht Deutschland? Berlin, 2. November 2015 Guter Zugang aber Qualität nicht immer überdurchschnittlich Themengebiet Ausgaben Zugang Ressourcen Inanspruchnahme Qualität Merkmale

Mehr

Mobile und soziale Kontaktpunkte beim Kauf von Bankprodukten Role of Mobile and Social in the Path to Purchase for Financial Services

Mobile und soziale Kontaktpunkte beim Kauf von Bankprodukten Role of Mobile and Social in the Path to Purchase for Financial Services T +9 221-2061-0 E info@yougov.de http://yougov.de/loesungen Ziel Die

Mehr

Audi Investor and Analyst Day 2011 Axel Strotbek

Audi Investor and Analyst Day 2011 Axel Strotbek Member of the Board of Management, Finance and Organization Economic development of key sales regions 2007 to [GDP in % compared with previous year] USA

Mehr

Chronische Niereninsuffizienz. Nicht jeder der pinkelt hat auch gesunde Nieren.

Chronische Niereninsuffizienz Nicht jeder der pinkelt hat auch gesunde Nieren. Chronische Niereninsufizienz 1) 1) Was hat sich nicht geändert? 2) 2) Was hat sich geändert? 3) 3) Was könnte sich ändern?

Mehr

Qualität t und Evidenz in der Ernährungsmedizin Sind Leitlinien eine Hilfe?

Qualität t und Evidenz in der Ernährungsmedizin Sind Leitlinien eine Hilfe? H. Lochs Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie h.lochs@charite.de Guidelines

Mehr